BUNGELTD - Quarter Report: 2023 September (Form 10-Q)

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-16625

BUNGE LIMITED

(Exact name of registrant as specified in its charter)


Bermuda						98-0231912
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1391 Timberlake Manor Parkway
Chesterfield
Missouri						63017
(Address of principal executive offices)						(Zip Code)

(314) 292-2000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares, $0.01 par value per share

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No ý

As of October 23, 2023, the number of common shares outstanding of the registrant was:

Common shares, par value $.01 per share:145,287,978

Table of Contents

BUNGE LIMITED

TABLE OF CONTENTS


		Page
PART I — FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Condensed Consolidated Statements of Income (Loss) for the Three and Nine Months Ended September 30, 2023 and 2022	3

	Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2023 and 2022	4

	Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022	5

	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022	6

	Condensed Consolidated Statements of Changes in Equity and Redeemable Noncontrolling Interests for the Three and Nine Months Ended September 30, 2023 and 2022	7

	Notes to the Condensed Consolidated Financial Statements	9

	Cautionary Statement Regarding Forward Looking Statements	40

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	41

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	58

Item 4.	Controls and Procedures	61

PART II — INFORMATION

Item 1.	Legal Proceedings	62

Item 1A.	Risk Factors	62

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	63

Item 3.	Defaults Upon Senior Securities	63

Item 4.	Mine Safety Disclosures	63

Item 5.	Other Information	63

Item 6.	Exhibits	63

Exhibit Index		64

Signatures		65

Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BUNGE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)

(U.S. dollars in millions, except per share data)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net sales	$	14,227	$	16,759	$	44,604	$	50,572
Cost of goods sold	(13,182)		(15,871)		(41,013)		(47,708)
Gross profit	1,045		888		3,591		2,864
Selling, general and administrative expenses	(447)		(337)		(1,220)		(979)
Interest income	38		30		121		50
Interest expense	(133)		(103)		(374)		(306)
Foreign exchange (losses) gains	(47)		(52)		(64)		(150)
Other income (expense) – net	8		40		35		(13)
Income (loss) from affiliates	39		30		83		95
Income (loss) before income tax	503		496		2,172		1,561
Income tax (expense) benefit	(114)		(113)		(495)		(257)
Net income (loss)	389		383		1,677		1,304


Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(16)		(3)		(50)		(30)
Net income (loss) attributable to Bunge	$	373	$	380	$	1,627	$	1,274
	0		0



Earnings per common share—basic (Note 18)


Net income (loss) attributable to Bunge common shareholders - basic	$	2.50	$	2.52	$	10.85	$	8.59

Earnings per common share—diluted (Note 18)


Net income (loss) attributable to Bunge common shareholders - diluted	$	2.47	$	2.49	$	10.71	$	8.30

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(U.S. dollars in millions)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net income (loss)	$	389	$	383	$	1,677	$	1,304
Other comprehensive income (loss):
Foreign exchange translation adjustment	(166)		(344)		102		(244)
Unrealized gains (losses) on designated hedges, net of tax (expense) benefit of $1 and $(2) in 2023 and zero and $(2) in 2022	31		32		(61)		(38)


Reclassification of net (gains) losses to net income, net of tax expense (benefit) of $3 and $2 in 2023 and zero and $12 in 2022	(2)		141		101		107
Total other comprehensive income (loss)	(137)		(171)		142		(175)
Total comprehensive income (loss)	252		212		1,819		1,129

Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(12)		8		(45)		20
Comprehensive income (loss) from acquisition of redeemable noncontrolling interest	—		(15)		—		(15)
Total comprehensive income (loss) attributable to Bunge	$	240	$	205	$	1,774	$	1,134

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(U.S. dollars in millions, except share data)


	September 30, 2023		December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	2,173	$	1,104

Trade accounts receivable (less allowances of $101 and $90) (Note 4)	2,509		2,829
Inventories (Note 5)	7,548		8,408
Assets held for sale (Note 2)	1		36
Other current assets (Note 6)	4,393		4,381
Total current assets	16,624		16,758
Property, plant and equipment, net	4,283		3,617
Operating lease assets	864		1,024
Goodwill	472		470
Other intangible assets, net	417		360
Investments in affiliates	1,201		1,012
Deferred income taxes	632		712

Other non-current assets (Note 7)	640		627
Total assets	$	25,133	$	24,580
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt (Note 13)	$	914	$	546
Current portion of long-term debt (Note 13)	301		846

Trade accounts payable (includes $926 and $643 carried at fair value) (Note 11)	3,975		4,386
Current operating lease obligations	317		425
Liabilities held for sale (Note 2)	—		18
Other current liabilities (Note 10)	2,738		3,379
Total current liabilities	8,245		9,600
Long-term debt (Note 13)	3,967		3,259
Deferred income taxes	380		365
Non-current operating lease obligations	495		547
Other non-current liabilities (Note 16)	900		849

Redeemable noncontrolling interest	3		4
Equity (Note 17):
Common shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2023 – 146,368,303 shares, 2022 – 149,907,932 shares	1		1
Additional paid-in capital	6,727		6,692
Retained earnings	11,555		10,222
Accumulated other comprehensive income (loss) (Note 17)	(6,224)		(6,371)
Treasury shares, at cost; 2023 - 23,163,348 shares and 2022 - 18,835,812 shares	(1,808)		(1,320)
Total Bunge shareholders’ equity	10,251		9,224
Noncontrolling interests	892		732
Total equity	11,143		9,956
Total liabilities, redeemable noncontrolling interest and equity	$	25,133	$	24,580

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(U.S. dollars in millions)


	Nine Months Ended September 30,
	2023		2022
OPERATING ACTIVITIES
Net income (loss)	$	1,677	$	1,304
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Impairment charges	56		86

Foreign exchange (gain) loss on net debt	(151)		(96)
Bad debt expense	8		23
Depreciation, depletion and amortization	317		305
Share-based compensation expense	51		47
Deferred income tax expense (benefit)	115		(92)

Results from affiliates	(100)		(95)
Other, net	57		80
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable	306		(359)
Inventories	933		(229)
Secured advances to suppliers	(228)		26
Trade accounts payable and accrued liabilities	(690)		259
Advances on sales	(227)		(81)
Net unrealized (gains) losses on derivative contracts	(247)		(456)
Margin deposits	(111)		(55)
Recoverable and income taxes, net	(19)		(201)
Marketable securities	(17)		341
Beneficial interest in securitized trade receivables	—		(5,288)
Other, net	130		(550)
Cash provided by (used for) operating activities	1,860		(5,031)
INVESTING ACTIVITIES
Payments made for capital expenditures	(805)		(353)

Proceeds from investments	21		217
Payments for investments	(26)		(225)
Settlements of net investment hedges	(57)		(153)
Proceeds from beneficial interest in securitized trade receivables	85		5,176

Proceeds from disposals of businesses and property, plant and equipment	165		496

Payments for investments in affiliates	(136)		(55)
Other, net	107		10
Cash provided by (used for) investing activities	(646)		5,113
FINANCING ACTIVITIES
Net change in short-term debt with maturities of three months or less	161		842
Proceeds from short-term debt with maturities greater than three months	848		1,592
Repayments of short-term debt with maturities greater than three months	(593)		(1,600)
Proceeds from long-term debt	975		48
Repayments of long-term debt	(879)		(1,029)
Proceeds from the exercise of options for common shares	7		30
Repurchases of common shares	(466)		(200)
Dividends paid to common and preference shareholders	(287)		(256)

Capital contributions from (Return of capital to) noncontrolling interest	40		—
Sale of noncontrolling interest	—		521
Acquisition of redeemable noncontrolling interest and noncontrolling interest	—		(102)
Other, net	(19)		52
Cash provided by (used for) financing activities	(213)		(102)
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale	40		112
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale	1,041		92
Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period	1,152		905
Cash and cash equivalents, restricted cash, and cash held for sale - end of period	$	2,193	$	997

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS

(Unaudited)

(U.S. dollars in millions, except share data)


			Convertible Preference Shares			Common Shares
	Redeemable Non- Controlling Interests		Shares	Amount		Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Shares		Non- Controlling Interests		Total Equity
Balance, July 1, 2023	$	4	—	$	—	150,630,209	$	1	$	6,706	$	11,279	$	(6,091)	$	(1,320)	$	783	$	11,358
Net income (loss)	(1)		—	—		—	—		—		373		—		—		17		390

Other comprehensive income (loss)	—		—	—		—	—		—		—		(133)		—		(4)		(137)

Dividends on common shares, $0.6625 per share	—		—	—		—	—		—		(96)		—		—		—		(96)

Dividends to noncontrolling interests on subsidiary common stock	—		—	—		—	—		—		—		—		—		(2)		(2)
Capital contribution (return) from (to) noncontrolling interest	—		—	—		—	—		—		—		—		—		7		7


Acquisition of noncontrolling interest (Note 8)	—		—	—		—	—		—		—		—		—		91		91

Share-based compensation expense	—		—	—		—	—		17		—		—		—		—		17

Repurchase of common shares	—		—	—		(4,327,536)	—		—		—		—		(488)		—		(488)

Issuance of common shares, including stock dividends	—		—	—		65,630	—		4		(1)		—		—		—		3
Balance, September 30, 2023	$	3	—	$	—	146,368,303	$	1	$	6,727	$	11,555	$	(6,224)	$	(1,808)	$	892	$	11,143



			Convertible Preference Shares			Common Shares
	Redeemable Non- Controlling Interests		Shares	Amount		Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Shares		Non- Controlling Interests		Total Equity
Balance, July 1, 2022	$	351	—	$	—	151,885,454	$	1	$	6,595	$	9,692	$	(6,436)	$	(1,120)	$	457	$	9,189
Net income (loss)	7		—	—		—	—		—		380		—		—		(4)		376

Other comprehensive income (loss)	11		—	—		—	—		—		—		(160)		—		(22)		(182)

Dividends on common shares, $0.625 per share	—		—	—		—	—		—		(92)		—		—		—		(92)


Acquisition of redeemable noncontrolling interest	(367)		—	—		—	—		45		—		(15)		—		235		265



Share-based compensation expense	—		—	—		—	—		15		—		—		—		—		15

Repurchase of common shares	—		—	—		(2,109,115)	—		—		—		—		(200)		—		(200)
Issuance of common shares, including stock dividends	—		—	—		20,571	—		—		—		—		—		—		—
Balance, September 30, 2022	$	2	—	$	—	149,796,910	$	1	$	6,655	$	9,980	$	(6,611)	$	(1,320)	$	666	$	9,371

Table of Contents


			Convertible Preference Shares			Common Shares
	Redeemable Non- Controlling Interests		Shares	Amount		Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Shares		Non- Controlling Interests		Total Equity
Balance, January 1, 2023	$	4	—	$	—	149,907,932	$	1	$	6,692	$	10,222	$	(6,371)	$	(1,320)	$	732	$	9,956
Net income (loss)	(1)		—	—		—	—		—		1,627		—		—		51		1,678

Other comprehensive income (loss)	—		—	—		—	—		—		—		147		—		(5)		142

Dividends on common shares, $1.95 per share	—		—	—		—	—		—		(290)		—		—		—		(290)

Dividends to noncontrolling interests on subsidiary common stock	—		—	—		—	—		—		—		—		—		(17)		(17)
Capital contribution (return) from (to) noncontrolling interest	—		—	—		—	—		—		—		—		—		40		40


Acquisition of noncontrolling interest (Note 8)	—		—	—		—	—		—		—		—		—		91		91

Share-based compensation expense	—		—	—		—	—		51		—		—		—		—		51
Repurchase of common shares	—		—	—		(4,327,536)	—		—		—		—		(488)		—		(488)

Issuance of common shares, including stock dividends	—		—	—		787,907	—		(16)		(4)		—		—		—		(20)
Balance, September 30, 2023	$	3	—	$	—	146,368,303	$	1	$	6,727	$	11,555	$	(6,224)	$	(1,808)	$	892	$	11,143


			Convertible Preference Shares			Common Shares

	Redeemable Non- Controlling Interests		Shares	Amount		Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Shares		Non- Controlling Interests		Total Equity
Balance, January 1, 2022	$	381	6,899,683	$	690	141,057,414	$	1	$	5,590	$	8,979	$	(6,471)	$	(1,120)	$	156	$	7,825
Net income (loss)	13		—	—		—	—		—		1,274		—		—		17		1,291
Other comprehensive income (loss)	(25)		—	—		—	—		—		—		(125)		—		(25)		(150)

Dividends on common shares, $1.775 per share	—		—	—		—	—		—		(268)		—		—		—		(268)

Dividends to noncontrolling interests on subsidiary common stock	—		—	—		—	—		—		—		—		—		(4)		(4)

Sale of noncontrolling interest	—		—	—		—	—		234		—		—		—		287		521
Acquisition of redeemable noncontrolling interest	(367)		—	—		—	—		45		—		(15)		—		235		265

Share-based compensation expense	—		—	—		—	—		47		—		—		—		—		47
Repurchase of common shares	—		—	—		(2,109,115)	—		—		—		—		(200)		—		(200)
Conversion of preference shares to common shares	—		(6,899,683)	(690)		8,863,331	—		690		—		—		—		—		—
Issuance of common shares, including stock dividends	—		—	—		1,985,280	—		49		(5)		—		—		—		44
Balance, September 30, 2022	$	2	—	$	—	149,796,910	$	1	$	6,655	$	9,980	$	(6,611)	$	(1,320)	$	666	$	9,371

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Limited ("Bunge" or the "Company"), its subsidiaries and variable interest entities ("VIEs") in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended ("Exchange Act"). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission ("SEC") rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2022 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2022, forming part of Bunge’s 2022 Annual Report on Form 10-K filed with the SEC on February 24, 2023.

Effective January 1, 2023, the Company changed its reporting of cash proceeds from and repayments of short-term debt with maturities of three months or less to be presented on a net basis in its condensed consolidated statements of cash flows. Prior to January 1, 2023, the Company presented cash proceeds from and repayments of short-term debt with maturities of three months or less separately in its consolidated statements of cash flows. Prior period amounts have been reclassified to conform to current presentation.

On December 8, 2022, Bunge announced the Company's intention to change the place of incorporation of Bunge's ultimate parent company from Bermuda to Switzerland (the "Redomestication"). Bunge shareholders approved the Redomestication at the Extraordinary General Meeting held on October 5, 2023. Bunge expects the Redomestication to occur in the fourth quarter of 2023, subject to various conditions. Please refer to the Company's definitive proxy statement filed with the SEC on August 7, 2023 for further details.

Throughout 2023 and 2022, Argentina’s government has published multiple Emergency Decrees (collectively referred to as the “Export Programs”) which have introduced preferential U.S. dollar to Argentine peso foreign exchange rates available exclusively during specific periods of time and payable to Argentinian farmers on qualifying Argentine peso denominated sales of certain commodities. The Export Programs are aimed at boosting farmer selling and in turn commodity exports. Bunge is both a receiver of the preferential exchange rate for cash converted to Argentine pesos, as well as a payer of the same preferential rate on purchases of various commodities from farmers and related export duties. Transactions related to these Export Programs were accounted for at the preferential rate. Please refer to Note 1 – Nature of Business, Basis of Presentation, and Significant Accounting Policies, included in the Company’s 2022 Annual Report on Form 10-K for further details on the 2022 Export Programs.

Ukraine-Russia War

On February 24, 2022, Russia initiated a military invasion of Ukraine (the "war"). Bunge’s Ukrainian operations comprise two oilseed crushing facilities, located in Mykolaiv and Dnipropetrovsk, a grain export terminal in Mykolaiv commercial seaport, numerous grain elevators, and an office in Kiev. The Company also operates a corn milling facility in Ukraine via a joint venture. As of September 30, 2023, total assets and total liabilities associated with Bunge’s Ukrainian subsidiaries each comprise approximately 2% of Bunge’s consolidated Total assets and Total liabilities, respectively.

Bunge’s operational activities in Ukraine have steadily increased during recent months, but remain limited and are subject to Bunge's ability to perform activities safely. On July 17, 2023, an agreement allowing the safe export of grain from three Ukrainian ports (Pivdennyi/Yuzhnvi, Odesa, and Chornomorsk; the "POC corridor") on the Black Sea expired. Following the termination of the POC corridor agreement, Russian attacks on key Ukrainian export infrastructure locations intensified. As of October 26, 2023, the termination of the POC corridor agreement and recent Russian attacks on key export infrastructure have not significantly impacted Bunge's results of operations in Ukraine as alternative routes to export product are being effectively utilized. The scope, intensity, duration, and outcome of the ongoing war is uncertain, and any continuation or escalation of the war may have a material adverse effect on Bunge, including its Ukrainian operations.

Table of Contents

In the three and nine months ended September 30, 2023, the Company recognized mark-to-market gains of $10 million and $29 million, respectively, in Cost of goods sold in the condensed consolidated statements of income related to inventory recovered from its Mykolaiv and other facilities which had no carrying value as of December 31, 2022. No impairments or charges related to the war were recorded in the three and nine months ended September 30, 2023. Please refer to Note 2 - Ukraine-Russia War, included in the Company's 2022 Annual Report on Form 10-K for further details regarding the impact of the war on Bunge's financial statements.

Cash, Cash Equivalents and Restricted Cash

Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the condensed consolidated statements of cash flows. The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows.


(US$ in millions)	September 30, 2023		September 30, 2022
Cash and cash equivalents	$	2,173	$	956
Restricted cash included in Other current assets	20		5
Cash and cash equivalents in Assets held for sale	—		36
Total	$	2,193	$	997

Cash paid for income taxes, net of refunds received, was $350 million and $383 million for the nine months ended September 30, 2023 and 2022, respectively. Cash paid for interest expense was $366 million and $315 million for the nine months ended September 30, 2023 and 2022, respectively.

Recently Adopted Accounting Pronouncements

In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848), to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting designed to ease the financial reporting burden related to reference rate reform. In December 2022, the FASB subsequently issued ASU 2022-06, Deferral of the Sunset Date of Topic 848, to ensure the relief in Topic 848 covers the period of time during which a significant number of modifications to eligible contracts and hedging relationships may take place. The ASU defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company is applying this guidance prospectively to all eligible contract modifications through December 31, 2024. As of September 30, 2023, Bunge has concluded the modification of all eligible contracts and the adoption of this guidance did not have a material impact on Bunge's condensed consolidated financial statements.

2. ACQUISITIONS AND DISPOSITIONS

Acquisitions

Viterra Limited Business Combination Agreement

On June 13, 2023, Bunge entered into a definitive business combination agreement (the "Agreement") with Viterra Limited ("Viterra") and its shareholders including certain affiliates of Glencore PLC, Canada Pension Plan Investment Board, and British Columbia Investment Management Corporation (collectively, the "Sellers"), to acquire Viterra in a stock and cash transaction. Bunge shareholders approved the acquisition at the Extraordinary General Meeting held October 5, 2023. The acquisition of Viterra by Bunge will create an innovative global agribusiness company well positioned to meet the demands of increasingly complex markets and better serve farmers and end-customers.

Under the terms of the Agreement, Viterra shareholders are anticipated to receive approximately 65.6 million of common shares of Bunge issued stock, with an aggregate value of approximately $7.1 billion as of September 30, 2023 and receive approximately $2.0 billion in cash (together, the "Transaction Consideration"), in return for 100% of the outstanding equity of Viterra. The determination of the final value of the Transaction Consideration will depend on the Company's share price at the time of closing. Upon completion of the transaction, the Sellers are expected to own approximately 30% of the combined Bunge company on a fully diluted basis, before giving effect to any future share repurchases by Bunge occurring after June 13, 2023.

Table of Contents

In connection with the execution of the Agreement, Bunge has secured a total of $8.0 billion in acquisition debt financing ("Acquisition Financing"). Bunge intends to use a portion of the Acquisition Financing to fund the cash portion of the Transaction Consideration, and the remainder for repayment of certain indebtedness of Viterra, which is expected to be repaid at closing, and for the ongoing operations of the combined company following closing. See Note 13 - Debt for further information.

The acquisition is expected to close in mid-2024, subject to the satisfaction of regulatory approvals and other customary closing conditions. The Agreement may be terminated by mutual written consent of the parties and includes certain customary termination rights. If the Agreement is terminated in connection with certain circumstances relating to the failure to obtain certain antitrust and competition clearances that are conditions to closing, Bunge would be obligated to pay the Sellers a fee of $400 million in the aggregate.

Additionally, on June 12, 2023 in contemplation of the Agreement, Bunge's Board of Directors approved a $1.7 billion expansion of the existing share repurchase program for the repurchase of Bunge's issued and outstanding common shares. Approximately $300 million remained outstanding under the existing program prior to the expansion of the program, resulting in an aggregate program size of up to $2.0 billion of repurchases of Bunge's issued and outstanding common shares. Under this program, Bunge repurchased 4,327,536 common shares for $488 million during the three and nine months ended September 30, 2023. Therefore, as of September 30, 2023, $1.5 billion remains outstanding for repurchases under the program. See Note 17 - Equity for further details on share repurchases.

CJ Selecta Share Purchase Agreement

On October 10, 2023, Bunge entered into a definitive share purchase agreement with CJ CheilJedang Corporation and STIC CJ Global Investment Corporate Partnership Private Equity Fund to acquire 100% of outstanding equity of CJ Latam Participações Ltda. and CJ Selecta S.A. (collectively, “CJ”) for a total cash consideration of approximately $510 million to be adjusted for net debt, plus an additional sum in consideration for the value of net working capital. Operations of CJ primarily consist of an oilseed processing facility located in Brazil. Bunge expects to finance the transaction through cash from operations and existing financing facilities. The acquisition is expected to close in 2024, subject to customary closing conditions.

Fuji Oils New Orleans, LLC Port Based Refinery

On April 14, 2023, Bunge, through its 80% ownership of Bunge Loders Croklaan joint venture with IOI Corporation Berhad, completed its purchase of Fuji Oils New Orleans, LLC's port based refinery. The refinery is located in International-Matex Tank Terminals' Avondale Terminal, in Avondale, Louisiana in the United States. Cash consideration for the asset acquisition of $181 million was allocated to Property, plant and equipment, net ($220 million), inclusive of a finance lease right of use asset ($52 million), long-term finance lease obligations ($41 million) included in Long-term debt and Current portion of long-term debt, and other net working capital ($2 million).

Dispositions

Russian Oilseed Processing and Refining Operations Disposition

On September 16, 2022, Bunge signed an agreement to sell its remaining Russian operations, primarily comprising an oilseed crushing and refining facility in Voronezh, southwest Russia (referred to as the "disposal group"), to Karen Vanetsyan (the "Buyer"), in exchange for a cash price approximately equal to the book value of the disposal group's net assets. On January 9, 2023, Bunge and the Buyer agreed to a purchase price adjustment. The purchase price adjustment and cumulative translation adjustment losses, among other items related to the disposal group, resulted in a corresponding impairment loss on sale of $103 million, recognized in Cost of goods sold for the year ended December 31, 2022. On February 3, 2023, the transaction closed in accordance with the terms of the agreement with no material impact to the condensed consolidated statement of income for the nine months ended September 30, 2023.

In connection with the transaction, Bunge agreed to indemnify the Buyer against certain legal claims involving Bunge's Russian subsidiary. Management has assessed the likelihood of any loss related to claims covered by the indemnity as remote, and recognized a liability in accordance with Accounting Standards Codification ("ASC") 460, Guarantees. See Note 15 - Commitments and Contingencies for more information.

The following table presents the book values of the major classes of assets and liabilities that were included in the disposal group at the closing date. Intercompany balances between the disposal group and other Bunge consolidated entities have been omitted. Assets included in the disposal group comprised $12 million and $21 million, reported under the Agribusiness segment and Refined and Specialty Oils segment, respectively. Liabilities included in the disposal group comprised $6 million and $13 million, reported under the Agribusiness segment and Refined and Specialty Oils segment, respectively.

Table of Contents


(US$ in millions)
Cash and cash equivalents	$	19
Trade accounts receivable (less allowances of zero)	15
Inventories	33

Other current assets	14
Property, plant and equipment, net	24

Goodwill & Other intangible assets, net	10
Other non-current assets	8
Impairment reserve	(90)
Total assets	$	33

Trade accounts payable and accrued liabilities	$	3


Other current liabilities	16


Total liabilities	$	19

3. TRADE STRUCTURED FINANCE PROGRAM

The Company engages in various trade structured finance activities to leverage the value of its global trade flows. These activities include programs under which the Company generally obtains U.S. dollar-denominated letters of credit ("LCs") from financial institutions, each based on an underlying commodity trade flow, and time deposits denominated in either the local currency of the financial institutions counterparties or in U.S. dollars, as well as foreign exchange forward contracts, in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements.

As of September 30, 2023 and December 31, 2022, time deposits and LCs of $5,551 million and $5,901 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting, had been met. The net losses and gains related to such activities are included as an adjustment to Cost of goods sold in the accompanying condensed consolidated statements of income. As of September 30, 2023 and December 31, 2022, time deposits, including those presented on a net basis, carried weighted-average interest rates of 5.71% and 3.46%, respectively. During the nine months ended September 30, 2023 and 2022, total net proceeds from issuances of LCs were $4,646 million and $5,045 million, respectively. These cash inflows were offset by the related cash outflows resulting from placement of the time deposits and repayment of the LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows.

As part of the trade structured finance activities, LCs may be sold to financial institutions on a discounted basis. Bunge does not service derecognized LCs. The terms of the sale may require the Company to continue to make periodic interest payments to financial institutions based on changes in the Secured Overnight Financing Rate ("SOFR") for a period of up to one year. Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current liabilities, including any unrealized gain or loss on changes in SOFR is not significant as of September 30, 2023 or December 31, 2022. The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 are included in Note 12 - Derivative Instruments And Hedging Activities. The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the three and nine month periods ended September 30, 2023 and 2022.

Table of Contents

4. TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM

Trade Accounts Receivable

Changes to the allowance for lifetime expected credit losses related to Trade accounts receivable were as follows:


	Nine Months Ended September 30, 2023
Rollforward of the Allowance for Credit Losses (US$ in millions)	Short-term		Long-term (1)		Total
Allowance as of January 1, 2023	$	90	$	46	$	136
Current period provisions	55		—		55
Recoveries	(44)		(2)		(46)
Write-offs charged against the allowance	(2)		(12)		(14)
Foreign exchange translation differences	2		—		2
Allowance as of September 30, 2023	$	101	$	32	$	133

(1) Long-term portion of the allowance for credit losses is included in Other non-current assets.


	Nine Months Ended September 30, 2022
Rollforward of the Allowance for Credit Losses (US$ in millions)	Short-term		Long-term (1)		Total
Allowance as of January 1, 2022	$	85	$	47	$	132
Current period provisions	49		1		50
Recoveries	(27)		(1)		(28)
Write-offs charged against the allowance	(11)		(3)		(14)
Foreign exchange translation differences	(2)		1		(1)
Allowance as of September 30, 2022	$	94	$	45	$	139

(1) Long-term portion of the allowance for credit losses is included in Other non-current assets.

Trade Receivables Securitization Program

Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the "Program") with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers (collectively, the "Purchasers"). Koninklijke Bunge B.V., a wholly owned subsidiary of Bunge, acts as master servicer, responsible for servicing and collecting the accounts receivable for the Program. The Program is designed to enhance Bunge’s financial flexibility by providing an additional source of liquidity for its operations.

Bunge may also, from time to time with the consent of the administrative agent, request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments by an amount not to exceed $250 million pursuant to an accordion provision. The Program includes sustainability provisions, pursuant to which the applicable margin will be increased or decreased based on Bunge's performance relative to certain sustainability targets, including, but not limited to, science-based targets that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025.

On June 21, 2023, Bunge and its finance subsidiaries terminated the Bunge Master Trust and amended the Program to remove all references and all provisions related to the Bunge Master Trust and to automatically assign Bunge Limited’s obligations as existing guarantor to Bunge Global SA as successor guarantor, effective at the completion of the Redomestication (see Note 13 - Debt). In addition, MUFG Bank, Ltd. and Gotham Funding Corporation were added as a Purchaser under the Program.

Table of Contents

On November 16, 2022, Bunge and certain of its subsidiaries amended the Program from a deferred purchase price structure to a pledge structure. Under the new structure, Bunge Securitization B.V. ("BSBV"), a consolidated bankruptcy remote special purpose entity, transfers certain trade receivables to the Purchasers in exchange for a cash payment up to $1.1 billion and retains ownership of a population of unsold receivables. BSBV agrees to guaranty the collection of sold receivables and grants a lien to the administrative agent on all unsold receivables. Collections on unsold receivables and guarantee payments are classified as operating activities in Bunge’s condensed consolidated statements of cash flows.

At November 16, 2022, the effective date of the amended Program, $741 million of sold receivables were repurchased through a non-cash investing exchange of the Deferred Purchase Price ("DPP"). As of September 30, 2023, the Company had collected a total of $731 million of repurchased receivables, including $85 million collected in the first nine months of 2023, which are reported as Proceeds from beneficial interest in securitized trade receivables under investing activities in the condensed consolidated statements of cash flows.

The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate earlier on May 17, 2025, unless extended for an additional period in accordance with the terms of the receivables transfer agreement.


(US$ in millions)	September 30, 2023		December 31, 2022
Receivables sold that were derecognized from Bunge's balance sheet	$	1,100	$	1,100
Unsold receivables pledged to the administrative agent and included in Trade accounts receivable	$	343	$	583

Bunge's risk of loss following the sale of trade receivables is limited to the assets of BSBV, primarily comprised of unsold receivables pledged to the administrative agent.

The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period.


	Nine Months Ended September 30,
(US$ in millions)	2023		2022
Gross receivables sold	$	10,231	$	13,182
Proceeds received in cash related to transfers of receivables (1)	$	10,186	$	12,455
Cash collections from customers on receivables previously sold	$	10,231	$	13,035
Discounts related to gross receivables sold included in Selling, general & administrative expenses	$	45	$	12

(1) Prior to November 16, 2022, the Company recognized these proceeds net of the DPP, consisting of a receivable from the Purchasers that entitled the Company to certain collections on the receivable. The Company recognized the collection of the DPP in net cash provided by investing activities in the condensed consolidated statements of cash flows. As a result of the November 16, 2022 amendment, Bunge reports collections on newly originated, unsold receivables held by BSBV as operating cash flows in the condensed consolidated statements of cash flows.

5. INVENTORIES

Inventories by segment are presented below. Readily marketable inventories ("RMI") are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. The Company engages in trading and distribution, or merchandising activities, and part of RMI can be attributable to such activities and is not held for processing. All other inventories are carried at lower of cost or net realizable value.

Table of Contents


(US$ in millions)	September 30, 2023		December 31, 2022
Agribusiness (1)	$	6,325	$	6,756
Refined and Specialty Oils (2)	1,047		1,316
Milling (3)	172		332
Corporate and Other	4		4
Total	$	7,548	$	8,408

(1) Includes RMI of $5,928 million and $6,286 million at September 30, 2023, and December 31, 2022, respectively. Assets held for sale includes RMI of zero and $26 million at September 30, 2023, and December 31, 2022, respectively. Of these amounts, $4,794 million and $4,789 million can be attributable to merchandising activities at September 30, 2023, and December 31, 2022, respectively.

(2) Includes RMI of $241 million and $271 million at September 30, 2023, and December 31, 2022, respectively.

(3) Includes RMI of $3 million and $97 million at September 30, 2023, and December 31, 2022, respectively.

6. OTHER CURRENT ASSETS

Other current assets consist of the following:


(US$ in millions)	September 30, 2023		December 31, 2022
Unrealized gains on derivative contracts, at fair value	$	1,506	$	1,597
Prepaid commodity purchase contracts (1)	544		254
Secured advances to suppliers, net (2)	318		365
Recoverable taxes, net	362		365
Margin deposits	898		791

Marketable securities and other short-term investments (3)	122		119
Income taxes receivable	39		102
Prepaid expenses	254		376
Restricted cash	20		26
Other	330		386
Total	$	4,393	$	4,381

(1) Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities.

(2) The Company provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The Company does not bear any of the costs or operational risks associated with the related growing activities. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to suppliers are reported net of allowances of $7 million at both September 30, 2023 and December 31, 2022.

(-) Interest earned on secured advances to suppliers of $6 million and $4 million for the three months ended September 30, 2023, and 2022, respectively, and $17 million and $16 million for the nine months ended September 30, 2023 and 2022, respectively, is included in Net sales in the condensed consolidated statements of income.

(3) Marketable securities and other short-term investments - The Company invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the Company's condensed consolidated balance sheets as marketable securities and other short-term investments.

Table of Contents


(US$ in millions)	September 30, 2023		December 31, 2022
Foreign government securities	$	81	$	68


Equity securities	6		23
Other	35		28
Total	$	122	$	119

As of September 30, 2023, and December 31, 2022, $86 million and $89 million, respectively, of marketable securities and other short-term investments were recorded at fair value. All other investments were recorded at cost, and due to the short-term nature of these investments, their carrying values approximated their fair values. For the three months ended September 30, 2023, and 2022, unrealized losses of $4 million and $9 million, respectively, have been recognized in Other income (expense) - net for investments held at September 30, 2023, and 2022. For the nine months ended September 30, 2023 and 2022, unrealized losses of $10 million and $123 million, respectively, have been recognized in Other income (expense) - net for investments held at September 30, 2023 and 2022.

7. OTHER NON-CURRENT ASSETS

Other non-current assets consist of the following:


(US$ in millions)	September 30, 2023		December 31, 2022
Recoverable taxes, net (1)	$	27	$	59
Judicial deposits (1)	120		110
Other long-term receivables, net (2)	14		16
Income taxes receivable (1)	170		143
Long-term investments (3)	143		163
Affiliate loans receivable	8		8
Long-term receivables from farmers in Brazil, net (1)	41		32
Unrealized gains on derivative contracts, at fair value	2		1
Other	115		95
Total	$	640	$	627

(1) A significant portion of these non-current assets arise from the Company’s Brazilian operations and their realization could take several years.

(2) Net of allowances as described in Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program.

(3) As of September 30, 2023, and December 31, 2022, $11 million and $9 million, respectively, of long-term investments are recorded at fair value.

Recoverable taxes, net - Recoverable taxes include value-added taxes paid upon the acquisition of property, plant and equipment, raw materials and taxable services, and other transactional taxes which can be recovered in cash or as compensation against income taxes, or other taxes Bunge may owe, primarily in Brazil and Europe. Recoverable taxes are reported net of allowances of $13 million and $14 million at September 30, 2023, and December 31, 2022, respectively.

Judicial deposits - Judicial deposits are funds the Company has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending resolution and bear interest at the Selic rate, which is the benchmark rate of the Brazilian central bank.

Income taxes receivable - Income taxes receivable include overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be primarily used for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate.

Long-term investments - Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures.

Affiliate loans receivable - Affiliate loans receivable are primarily interest-bearing receivables from unconsolidated affiliates with remaining maturities of greater than one year.

Table of Contents

Long-term receivables from farmers in Brazil, net - The Company provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest of the then-current year’s crop, and through credit sales of fertilizer to farmers. Certain such long-term receivables from farmers are originally recorded in Other current assets as prepaid commodity purchase contracts or secured advances to suppliers (see Note 6 - Other Current Assets) or Other non-current assets according to their maturity. Advances initially recorded in Other current assets are reclassified to Other non-current assets if collection issues arise and amounts become past due with resolution of such matters expected to take more than one year.

The average recorded investment in long-term receivables from farmers in Brazil for the nine months ended September 30, 2023, and the year ended December 31, 2022, was $93 million and $90 million, respectively. The table below summarizes the Company’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts.


	September 30, 2023				December 31, 2022
(US$ in millions)	Recorded Investment		Allowance		Recorded Investment		Allowance
For which an allowance has been provided:
Legal collection process (1)	$	31	$	29	$	40	$	34
Renegotiated amounts	2		2		2		2
For which no allowance has been provided:
Legal collection process (1)	17		—		19		—
Renegotiated amounts (2)	5		—		7		—
Other long-term receivables (3)	17		—		—		—
Total	$	72	$	31	$	68	$	36

(1) All amounts in legal collection processes are considered past due upon initiation of legal action.

(2) These renegotiated amounts are current on repayment terms.

(3) New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date. Such advances are reclassified from Other non-current assets to Other current assets in later periods depending on the expected date of their realization.

The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil.


	Nine Months Ended September 30,
(US$ in millions)	2023		2022
Allowance as of January 1	$	36	$	36
Bad debt provisions	1		2
Recoveries	(3)		(6)
Write-offs	(5)		(1)
Transfers	—		1
Foreign exchange translation	2		2
Allowance as of September 30	$	31	$	34

8. INVESTMENTS IN AFFILIATES AND VARIABLE INTEREST ENTITIES

Impairment of Equity Method Investment

During the nine months ended September 30, 2023, the Company recorded an impairment of $16 million associated with its equity method investment in Australia Plant Proteins ("APP"), a start-up manufacturer of novel protein ingredients. The impairment was determined through management's review of impairment indicators and consideration of the other-than temporary nature of such items. Impairment charges were recorded to Income (loss) from affiliates within Corporate and Other. As a result of the impairment, there is no carrying value associated with the equity method investment in APP at September 30, 2023.

Table of Contents

Consolidated Variable Interest Entities

On September 19, 2023, Bunge entered into a fixed-priced call option agreement ("Option") to acquire the shares of Terminal de Granéis de Santa Catarina ("TGSC") with primary assets consisting of a grain port terminal currently under construction in South America strategically located near an existing Bunge facility. The agreement requires Bunge to make future installment payments for the Option which will be utilized, in part, to fund terminal construction. Required installment payments prior to the exercise of the Option are not material and are expected to be applied against the exercise price of the Option. TGSC is a variable interest entity ("VIE") as a result of having insufficient equity at risk. Bunge is the primary beneficiary due to a de facto agent relationship with the equity owner of TGSC and has consolidated the entity. As all of TGSC’s equity is held by a third-party, Bunge reflects all TGSC earnings and equity as attributable to noncontrolling interests in the condensed consolidated statements of income and condensed consolidated balance sheets, respectively.

TGSC is not a business as defined by U.S. GAAP. Therefore, the non-cash transaction resulting in initial consolidation of TGSC in the third quarter of 2023 represents an asset acquisition. Positions recognized in the condensed consolidated balance sheet upon initial consolidation consisted primarily of Other intangible assets, net - license ($87 million); Property, plant and equipment, net - construction-in-process ($36 million); Long-term debt ($35 million); and Noncontrolling interests ($91 million). Bunge did not recognize any gain or loss upon initial consolidation of TGSC. TGSC's assets can only be used to settle the entity’s own obligations and TGSC’s creditors have no recourse to Bunge’s assets beyond Bunge’s maximum exposure to loss associated with TGSC at any given time.

On May 1, 2022, Bunge completed a transaction with Chevron Corporation ("Chevron") to create a joint venture, Bunge Chevron Ag Renewables LLC (the "Joint Venture"), leveraging Bunge’s expertise in oilseed processing and farmer relationships, and Chevron’s expertise in fuels manufacturing and marketing, to help meet the demand for renewable fuels and to develop lower carbon intensity feedstocks.

The Joint Venture is a VIE in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of the Joint Venture as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by the Joint Venture, among other factors. The Joint Venture's assets can only be used to settle the Joint Venture’s own obligations and the Joint Venture’s creditors have no recourse to Bunge’s assets beyond Bunge’s maximum exposure to loss associated with the Joint Venture at any given time.

The following table presents the values of the assets and liabilities associated with the above listed VIEs in which Bunge is considered the primary beneficiary to the extent included in Bunge’s condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. All amounts exclude intercompany balances, which have been eliminated upon consolidation.

For all other VIEs in which Bunge is considered the primary beneficiary, the entities meet the definition of a business, and the VIE's assets can be used other than for the settlement of the VIE’s obligations. As such these VIEs have been excluded from the below table.

Table of Contents


(US$ in millions)	September 30, 2023		December 31, 2022
Current assets:
Cash and cash equivalents	$	586	$	528
Trade accounts receivable	2		—
Inventories	55		85
Other current assets	116		98
Total current assets	759		711
Property, plant and equipment, net	151		65

Other intangible assets, net	87		—


Total assets	$	997	$	776

Current liabilities:
Trade accounts payable and accrued liabilities	$	65	$	81


Other current liabilities	118		85
Total current liabilities	183		166
Long-term debt	35		—



Total liabilities	$	218	$	166

For additional information on VIEs for which Bunge has determined it is not the primary beneficiary, along with the Company's related maximum exposure to losses associated with such investments, please refer to Note 12 - Investments in Affiliates and Variable Interest Entities, included in the Company's 2022 Annual Report on Form 10-K.

9. INCOME TAXES

Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-recurring tax adjustments in the interim period in which they occur. In addition, results from jurisdictions projecting a loss for the year where no tax benefit can be recognized are treated discretely in the interim period in which they occur. The effective tax rate is highly dependent on the geographic distribution of the Company’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate, including the realizability of deferred tax assets, and adjusts estimates accordingly. Volatility in earnings within a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted.

Income tax expense for the three and nine months ended September 30, 2023 was $114 million and $495 million, respectively. Income tax expense for the three and nine months ended September 30, 2022 was $113 million and $257 million, respectively. The effective tax rate for the three and nine months ended September 30, 2023, was higher than the U.S. statutory rate of 21% primarily due to jurisdictional mix of earnings. The effective tax rate for the three months ended September 30, 2022, was higher than the U.S. statutory rate of 21% primarily due to unfavorable tax impact on North American and expected European dispositions and the effective tax rate for the nine months ended September 30, 2022, was lower than the U.S. statutory rate of 21%, primarily due to jurisdictional mix of earnings, incentives in South America, and the release of valuation allowances in Europe and Asia.

As a global enterprise, the Company files income tax returns that are subject to periodic examination and challenge by federal, state, and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or litigation, may take several years to finalize. The Company is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.

Table of Contents

10. OTHER CURRENT LIABILITIES

Other current liabilities consist of the following:


(US$ in millions)	September 30, 2023		December 31, 2022
Unrealized losses on derivative contracts, at fair value	$	1,222	$	1,570
Accrued liabilities	746		755
Advances on sales (1)	372		601

Income tax payable	44		156
Other	354		297
Total	$	2,738	$	3,379

(1) The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.

11. FAIR VALUE MEASUREMENTS

Bunge's various financial instruments include certain components of working capital such as Trade accounts receivable and Trade accounts payable. Additionally, Bunge uses short- and long-term debt to fund operating requirements. Trade accounts receivable, Trade accounts payable, and Short-term debt are generally stated at their carrying value, which is a reasonable estimate of fair value. See Note 3 - Trade Structured Finance Program for trade structured finance program, Note 7 - Other Non-Current Assets for long-term receivables from farmers in Brazil, net and other long-term investments, and Note 13 - Debt for Long-term debt. Bunge's financial instruments also include derivative instruments and marketable securities, which are stated at fair value.

The fair value standard describes three levels within its hierarchy that may be used to measure fair value.


Level	Description	Financial Instrument (Assets / Liabilities)
Level 1	Quoted prices (unadjusted) in active markets for identical assets or liabilities.	Exchange traded derivative contracts. Marketable securities in active markets.
Level 2	Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.	Exchange traded derivative contracts (less liquid markets). Readily marketable inventories. Over-the-counter ("OTC") commodity purchase and sales contracts. OTC derivatives whose value is determined using pricing models with inputs that are generally based on exchange traded prices, adjusted for location specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data. Marketable securities in less active markets.
Level 3	Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities.	Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques. Assets and liabilities for which the determination of fair value requires significant management judgment or estimation.

In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.

For a further definition of fair value and the associated fair value levels, refer to Note 16 - Fair Value Measurements, included in the Company's 2022 Annual Report on Form 10-K.

Table of Contents

The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis.


	Fair Value Measurements at Reporting Date
	September 30, 2023								December 31, 2022
(US$ in millions)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents	$	115	$	133	$	—	$	248	$	—	$	81	$	—	$	81
Readily marketable inventories (Note 5)	—		5,078		1,094		6,172		—		6,268		412		6,680
Trade accounts receivable (1)	—		1		—		1		—		7		—		7
Unrealized gain on derivative contracts (2):
Interest rate	1		10		—		11		—		3		—		3
Foreign exchange	—		314		—		314		1		378		—		379
Commodities	170		792		80		1,042		136		763		101		1,000
Freight	76		—		—		76		80		—		—		80
Energy	64		1		—		65		128		2		—		130
Credit	—		—		—		—		—		5		—		5


Other (3)	17		68		12		97		33		40		27		100
Total assets	$	443	$	6,397	$	1,186	$	8,026	$	378	$	7,547	$	540	$	8,465
Liabilities:
Trade accounts payable (1)	$	—	$	615	$	311	$	926	$	—	$	513	$	130	$	643
Unrealized loss on derivative contracts (4):
Interest rate	—		375		—		375		—		344		—		344
Foreign exchange	—		345		—		345		1		461		—		462
Commodities	181		554		41		776		127		731		50		908
Freight	32		—		—		32		28		—		—		28
Energy	56		2		—		58		153		6		—		159
Credit	—		—		—		—		—		1		—		1

Total liabilities	$	269	$	1,891	$	352	$	2,512	$	309	$	2,056	$	180	$	2,545

(1) These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business.

(2) Unrealized gains on derivative contracts are generally included in Other current assets. There were $2 million and $1 million included in Other non-current assets at September 30, 2023, and December 31, 2022, respectively.

(3) Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets.

(4) Unrealized losses on derivative contracts are generally included in Other current liabilities. There were $364 million and $332 million included in Other non-current liabilities at September 30, 2023, and December 31, 2022, respectively.

Cash equivalents —Cash equivalents primarily includes money market funds and commercial paper investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Cash equivalents with liquid prices are valued using prices from publicly available sources and classified as Level 1. Cash equivalents with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2.

Readily marketable inventories—RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where the Company's inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.

If the Company used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported

Table of Contents

in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.

Derivatives—The majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. The majority of the Company’s exchange traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. The Company's forward commodity purchase and sales contracts are classified as derivatives along with other OTC derivative instruments, primarily relating to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3 as described below. The Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations, or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2.

OTC derivative contracts include swaps, options, and structured transactions that are generally fair valued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices, and indices, to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market.

Marketable securities and investments—Comprise foreign government securities, corporate debt securities, deposits, equity securities, and other investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Marketable securities and investments with liquid prices are valued using prices from publicly available sources and classified as Level 1. Marketable securities and investments with less liquid prices are valued using third-party quotes or pricing models and classified as Level 2 or Level 3 as described below.

Level 3 Measurements

The following relates to Level 3 measurements. An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable.

Level 3 Measurements—Transfers in and/or out of Level 3 represent existing assets or liabilities that were either previously categorized as a higher level for which the inputs to the model became unobservable or assets and liabilities that were previously classified as Level 3 for which the lowest significant input became observable during the period. Bunge's policy regarding the timing of transfers between levels is to record the transfers at the end of the reporting period.

Level 3 Readily marketable inventories and Trade accounts payable—The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sales contracts, and Trade accounts payable, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, the Company uses proprietary information such as purchase and sales contracts and contracted prices to value freight, premiums and discounts in its contracts. Movements in the prices of these unobservable inputs alone would not be expected to have a material effect on the Company's financial statements as these contracts do not typically exceed one future crop cycle.

Level 3 Derivatives—Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements. These inputs include commodity prices, price volatility, interest rates, volumes, and locations.

Level 3 Others—Primarily relates to marketable securities and investments valued using third-party quotes or pricing models with inputs based on similar securities adjusted to reflect management’s best estimate of the specific characteristics of the securities held by the Company. Such inputs represent a significant component of the fair value of the securities held by the Company, resulting in the securities being classified as Level 3.

The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2023, and 2022. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant.

Table of Contents



	Three Months Ended September 30, 2023
(US$ in millions)	Readily Marketable Inventories		Derivatives, Net		Trade Accounts Payable		Other(2)		Total
Balance, July 1, 2023	$	1,384	$	9	$	(437)	$	11	$	967
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)	300		39		3		—		342

Total gains and losses (realized/unrealized) included in Other income (expense) - net	—		—		—		1		1
Purchases	1,001		—		(21)		—		980
Sales	(1,694)		—		—		—		(1,694)

Settlements	—		—		158		—		158
Transfers into Level 3	415		22		(32)		—		405
Transfers out of Level 3	(271)		(31)		2		—		(300)
Translation adjustment	(41)		—		16		—		(25)
Balance, September 30, 2023	$	1,094	$	39	$	(311)	$	12	$	834

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $207 million, $24 million and $3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023.

(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $1 million mark-to-market losses related to securities still held at September 30, 2023.



	Three Months Ended September 30, 2022
(US$ in millions)	Readily Marketable Inventories		Derivatives, Net		Trade Accounts Payable		Other (2)		Total
Balance, July 1, 2022	$	941	$	10	$	(271)	$	66	$	746
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)	251		60		3		—		314
Total gains and losses (realized/unrealized) included in Foreign exchange (losses) gains	—		—		—		(7)		(7)
Total gains and losses (realized/unrealized) included in Other income (expense) - net	—		—		—		(7)		(7)
Purchases	732		—		(63)		—		669
Sales	(1,584)		—		—		—		(1,584)

Settlements	—		—		69		(16)		53
Transfers into Level 3	727		(3)		(88)		—		636
Transfers out of Level 3	(182)		(7)		—		—		(189)
Translation adjustment	(25)		—		8		—		(17)
Balance, September 30, 2022	$	860	$	60	$	(342)	$	36	$	614

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $313 million, $62 million and $3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2022.

(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $7 million in mark-to-market losses related to securities still held at September 30, 2022.

Table of Contents




	Nine Months Ended September 30, 2023
(US$ in millions)	Readily Marketable Inventories		Derivatives, Net		Trade Accounts Payable		Other(2)		Total
Balance, January 1, 2023	$	412	$	51	$	(130)	$	27	$	360
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)	665		(32)		21		—		654

Total gains and losses (realized/unrealized) included in Other income (expense) - net	—		—		—		(1)		(1)
Purchases	4,022		—		(450)		—		3,572
Sales	(5,283)		—		—		(14)		(5,297)

Settlements	—		—		329		—		329
Transfers into Level 3	1,565		51		(113)		—		1,503
Transfers out of Level 3	(310)		(31)		44		—		(297)
Translation adjustment	23		—		(12)		—		11
Balance, September 30, 2023	$	1,094	$	39	$	(311)	$	12	$	834

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, include gains/(losses) of $648 million, $(20) million and $22 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2023.

(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $15 million mark-to-market losses related to securities still held at September 30, 2023.



	Nine Months Ended September 30, 2022
(US$ in millions)	Readily Marketable Inventories		Derivatives, Net		Trade Accounts Payable		Other(2)		Total
Balance, January 1, 2022	$	205	$	(31)	$	(23)	$	—	$	151
Total gains and losses (realized/unrealized) included in Cost of goods sold (1)	421		87		36		—		544
Total gains and losses (realized/unrealized) included in Foreign exchange (losses) gains	—		—		—		(7)		(7)
Total gains and losses (realized/unrealized) included in Other income (expense) - net	—		—		—		(76)		(76)
Purchases	2,834		—		(509)		—		2,325
Sales	(4,271)		—		—		—		(4,271)

Settlements	—		—		394		(101)		293
Transfers into Level 3	2,142		25		(434)		218		1,951
Transfers out of Level 3	(360)		(21)		146		—		(235)
Translation adjustment	(111)		—		48		2		(61)
Balance, September 30, 2022	$	860	$	60	$	(342)	$	36	$	614

(1) Readily marketable inventories, derivatives, net, and Trade accounts payable, includes gains/(losses) of $480 million, $89 million and $30 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2022.

(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $45 million in mark-to-market losses related to securities still held at September 30, 2022.

Table of Contents

12. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency, and commodity risk. Some of those hedges the Company enters into qualify for hedge accounting in the financial statements (Hedge Accounting Derivatives) and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting (Economic Hedge Derivatives). As these derivatives impact the financial statements in different ways, they are discussed separately below.

Hedge Accounting Derivatives - The Company uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, foreign currency, and commodity risks. In executing these hedge strategies, the Company primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative.

Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of a change in the fair value of the derivative will be substantially offset by the earnings effect of the change in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. For cross currency swaps the changes in currency risk on the derivative are recognized in Foreign exchange gains (losses), and the changes in interest rate risk are recognized in Interest expense. Changes in basis risk are held in Accumulated other comprehensive income (loss) until realized through the coupon.

Cash flow hedges of currency risk - The Company manages currency risk on certain forecasted sales, purchases, selling, general and administrative expenses, and recognized assets and liabilities with currency forwards. The change in the value of the forward is held in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the currency forward is reclassified to Net sales, Cost of goods sold, or Selling, general and administrative expenses. These hedges mature at various times through December 2024. Of the amount currently in Accumulated other comprehensive income (loss), $2 million of deferred losses is expected to be reclassified to earnings in the next twelve months.

Net investment hedges - The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings by way of either sale or substantial liquidation of the foreign subsidiary.

The table below provides information about the balance sheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis.

Table of Contents


(US$ in millions)		September 30, 2023		December 31, 2022		Unit of Measure
Hedging instrument type:
Fair value hedges of interest rate risk
	Interest rate swap - notional amount	$	2,900	$	3,753	$ Notional
	Cumulative adjustment to long-term debt from application of hedge accounting	$	(363)	$	(341)	$ Notional
	Carrying value of hedged debt	$	2,522	$	3,394	$ Notional

Fair value hedges of currency risk
	Cross currency swap	$	206	$	232	$ Notional

	Carrying value of hedged debt	$	206	$	232	$ Notional




Cash flow hedges of currency risk
	Foreign currency forward - notional amount	$	57	$	310	$ Notional
	Foreign currency option - notional amount	$	117	$	108	$ Notional




Net investment hedges
	Foreign currency forward - notional amount	$	1,023	$	495	$ Notional

Economic Hedge Derivatives - In addition to using derivatives in qualifying hedge relationships, the Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations.

Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances. The impact of changes in fair value of these instruments is primarily presented in Interest expense.

Currency derivatives are used to hedge the balance sheet and commercial exposures that arise from the Company's global operations. The impact of changes in fair value of these instruments is presented in Cost of goods sold when hedging commercial exposures and Foreign exchange (losses) gains when hedging monetary exposures.

Agricultural commodity derivatives are used primarily to manage the Company's inventory and forward purchase and sales contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company uses derivative instruments referred to as forward freight agreements ("FFAs") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company uses energy derivative instruments to manage its exposure to volatility in energy costs. Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

Table of Contents

The table below summarizes the volume of economic derivatives as of September 30, 2023 and December 31, 2022. For those contracts traded bilaterally through the over-the-counter markets (e.g., forwards, forward rate agreements ("FRA"), and swaps), the gross position is provided. For exchange traded (e.g., futures, FFAs, and options) and cleared positions (e.g., energy swaps), the net position is provided.


	September 30,				December 31,
	2023				2022				Unit of Measure
(US$ in millions)	Long		(Short)		Long		(Short)
Interest rate
Swaps	$	115	$	(1,630)	$	387	$	(1,267)	$ Notional
Futures	$	—	$	(313)	$	—	$	(97)	$ Notional
Forwards	$	631	$	(860)	$	—	$	—	$ Notional
Currency
Forwards	$	9,714	$	(12,459)	$	9,819	$	(9,682)	$ Notional
Swaps	$	2,292	$	(1,019)	$	2,441	$	(2,876)	$ Notional
Futures	$	—	$	(4)	$	11	$	—	$ Notional
Options	$	58	$	(35)	$	—	$	(102)	Delta
Agricultural commodities
Forwards	29,271,422		(36,196,274)		20,493,679		(27,766,763)		Metric Tons
Swaps	—		—		—		(1,864,262)		Metric Tons
Futures	—		(5,099,604)		—		(4,092,772)		Metric Tons
Options	221,203		(288,927)		1,025		(216,647)		Metric Tons
Ocean freight
FFA	—		(4,965)		—		(11,197)		Hire Days

Natural gas
Forwards	6,336		(6,336)		—		—		MMBtus
Swaps	927,014		—		1,460,190		—		MMBtus
Futures	4,289,892		—		5,250,393		—		MMBtus
Options	2,622,078		—		—		—		MMBtus
Electricity

Futures	40,267		—		—		—		Mwh

Swaps	—		—		22,987		(8,619)		Mwh
Energy - other
Swaps	189,731		—		175,784		—		Metric Tons
Futures	16,360		—		1,320,881		—		Metric Tons
Options	—		(27,280)		—		—		Metric Tons
Energy - CO2
Futures	826,000		—		—		(38,000)		Metric Tons
Other
Swaps and futures	$	10	$	(15)	$	20	$	(50)	$ Notional

Table of Contents

The Effect of Derivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income

The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2023 and 2022.


		Gain (Loss) Recognized in Income on Derivative Instruments
		Three Months Ended September 30,
(US$ in millions)		2023		2022
Income statement classification	Type of derivative
Net sales
Hedge accounting	Foreign currency	$	2	$	—

Cost of goods sold


Hedge accounting	Foreign currency	$	1	$	3
Economic hedges	Foreign currency	(41)		59
	Commodities	30		303
	Other (1)	79		(3)
Total Cost of goods sold		$	69	$	362




Selling, general & administrative
Hedge Accounting	Foreign exchange	$	—	$	(1)

Interest expense
Hedge accounting	Interest rate	$	(35)	$	(8)

Total Interest expense		$	(35)	$	(8)

Foreign exchange (losses) gains
Hedge accounting	Foreign currency	$	(5)	$	2
Economic hedges	Foreign currency	10		14
Total Foreign exchange (losses) gains		$	5	$	16

Other income (expense)
Economic hedges	Interest rate	$	(1)	$	1




Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period		$	1	$	(2)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period		$	10	$	38

Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period		$	20	$	(4)



Amounts released from Accumulated other comprehensive income (loss) during the period


Cash flow hedge of foreign currency risk		$	(1)	$	(18)

(1) Other includes results from freight, energy, and other derivatives.

Table of Contents



		Gain (Loss) Recognized in Income on Derivative Instruments
		Nine months ended September 30,
(US$ in millions)		2023		2022
Income statement classification	Type of derivative
Net sales
Hedge accounting	Foreign currency	$	6	$	7

Cost of goods sold
Hedge accounting	Foreign currency	$	1	$	3

Economic hedges	Foreign currency	367		482
	Commodities	394		(318)
	Other (1)	86		90
Total Cost of goods sold		$	848	$	257

Selling, general & administrative expenses
Hedge Accounting	Foreign exchange	$	1	$	(1)

Interest expense
Hedge accounting	Interest rate	$	(103)	$	(12)
Economic hedges	Interest rate	6		1
Total Interest expense		$	(97)	$	(11)

Foreign exchange (losses) gains
Hedge accounting	Foreign currency	$	(26)	$	(35)
Economic hedges	Foreign currency	4		130
Total Foreign exchange (losses) gains		$	(22)	$	95

Other income (expense)
Economic hedges	Interest rate	$	1	$	2


Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in Other comprehensive income (loss) during the period		$	1	$	—
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in Other comprehensive income (loss) during the period		$	(21)	$	72

Gains and losses on derivatives used as net investment hedges included in Other comprehensive income (loss) during the period		$	(41)	$	(110)


Amounts released from Accumulated other comprehensive income (loss) during the period


Cash flow hedge of foreign currency risk		$	(1)	$	(25)

(1) Other includes results from freight, energy, and other derivatives.

Table of Contents

13. DEBT

Prior to June 21, 2023, Bunge conducted most of its third party financing activities through a centralized financing structure that included a master trust (the “Bunge Master Trust”). On June 21, 2023, Bunge terminated the Bunge Master Trust in accordance with a termination and lien release agreement in order to simplify the legal framework around its capital structure. Post termination of the Bunge Master Trust, Bunge will continue to conduct most of its third party financing activities centrally through 100% owned finance subsidiaries which carry full, unconditional guarantees of the parent company. In connection with the termination of the Bunge Master Trust, Bunge amended its existing credit agreements and related guarantees to remove all references and provisions related to the Bunge Master Trust, as well as made amendments to certain credit facilities as discussed further below.

Also on June 21, 2023, Bunge entered into an unsecured $1.1 billion 364-day revolving credit agreement (the “$1.1 Billion 2024 Credit Agreement”) with a group of lenders, maturing on June 19, 2024. Bunge may from time to time request one or more of the existing or new lenders to increase the total participations under the $1.1 Billion 2024 Credit Agreement by an aggregate amount up to $250 million, subject to lender approval, pursuant to an accordion provision. Borrowings will bear interest at Secured Overnight Financing Rate (“SOFR”) plus a SOFR adjustment and applicable margin as defined in the $1.1 Billion 2024 Credit Agreement. The $1.1 Billion 2024 Credit Agreement replaced an existing $1.1 billion 364-day revolving credit agreement scheduled to mature July 14, 2023. Bunge had no borrowings outstanding at September 30, 2023, and December 31, 2022, under the $1.1 Billion 2024 Credit Agreement and the predecessor agreement, respectively.

Further, on June 21, 2023, Bunge amended its $1.35 billion 5-year revolving credit agreement to increase total commitments under the facility to $1.95 billion (the “$1.95 Billion Credit Agreement"). Bunge may from time to time request one or more of the existing or new lenders to increase the total participations under the $1.95 Billion Credit Agreement by an aggregate amount up to $1.5 billion pursuant to an accordion provision. Borrowings will bear interest at SOFR plus a SOFR adjustment and applicable margin as defined in the $1.95 Billion Credit Agreement. Bunge had no borrowings outstanding at September 30, 2023, and December 31, 2022, under the $1.95 Billion Credit Agreement.

Bunge had no borrowings outstanding at September 30, 2023, and December 31, 2022, under the unsecured $865 million Revolving Credit Agreement (the "$865 Million 2026 Facility") with a group of lenders, set to mature on October 29, 2026. Borrowings will bear interest at SOFR plus a SOFR adjustment and applicable margin, as defined in the $865 Million 2026 Facility.

Bunge had no borrowings outstanding at September 30, 2023, and December 31, 2022, under the unsecured $1.75 billion revolving credit facility, set to mature on December 16, 2024 and terminated on October 6, 2023 ("Terminated $1.75 Billion Revolving Credit Facility"). On October 6, 2023, Bunge replaced the capacity of the Terminated $1.75 Billion Revolving Credit Facility by entering into an unsecured $1.75 billion revolving credit facility ("$1.75 Billion Revolving Credit Facility"), with a group of lenders, maturing on October 6, 2026. Bunge may from time to time, with the consent of the agent, request one or more of the existing lenders or new lenders to increase the total commitments in an amount not to exceed $1.75 billion pursuant to an accordion provision. Bunge has the option to request an extension of the maturity date of the $1.75 Billion Revolving Credit Facility for two additional one-year periods. Borrowings under the $1.75 Billion Revolving Credit Facility will bear interest at SOFR plus a SOFR adjustment, which will vary from 0.05% to 0.25% based on the tenor of the interest period selected, plus a margin, which will vary from 0.25% to 0.90%, based on the senior long-term unsecured debt rating provided by Moody’s Investors Services Inc. (“Moody’s”) and S&P Global Ratings ("S&P"). The applicable margin is also subject to certain premiums or discounts tied to certain sustainability criteria, including, but not limited to, science based targets (SBTs) that define Bunge’s climate goals within its operations and a commitment to eliminate deforestation in its supply chains in 2025.

Borrowings under the committed revolving credit facilities described above typically have an original maturity of three months or less, resulting in net presentation of proceeds and repayments of short-term debt in the condensed consolidated statements of cash flows.

At September 30, 2023, Bunge had $5,665 million unused and available committed borrowing capacity comprised of committed revolving credit facilities with a number of financial institutions. At December 31, 2022, Bunge had $6,665 million unused and available committed borrowing capacity comprised of committed revolving credit facilities and the commercial paper program with a number of financial institutions, totaling $5,665 million, and $1,000 million in committed unsecured delayed draw term loans, as discussed below.

Table of Contents

On June 21, 2023, Bunge terminated its existing $600 million asset-backed commercial paper program and its related liquidity and letter of credit facilities. To continue access to the commercial paper market, Bunge established a new $1 billion unsecured corporate commercial paper program (the “$1 Billion Commercial Paper Program”). S&P and Moody's assigned short-term ratings of A-2 and P-2, respectively. The short-term credit ratings of the $1 Billion Commercial Paper Program require Bunge to keep same day unused committed borrowing capacity under its long-term committed credit facilities in an amount greater or equal to the amount of commercial paper issued and outstanding. The $1 Billion Commercial Paper Program has no maturity date. At September 30, 2023, there were no borrowings outstanding under the $1 Billion Commercial Paper Program. At December 31, 2022, there were no borrowings outstanding under Bunge’s prior commercial paper program and its related liquidity and letter of credit facilities. Borrowings under the $1 Billion Commercial Paper Program typically have an original maturity of three months or less, resulting in net presentation of proceeds and repayments of short-term debt in the condensed consolidated statements of cash flows.

In addition to committed facilities, from time to time, Bunge Limited and/or its financing subsidiaries enter into uncommitted bilateral short-term credit lines as necessary based on financing requirements. At September 30, 2023, and December 31, 2022, there were no borrowings, respectively, outstanding under these bilateral short-term credit lines. Loans under such credit lines are non-callable by the respective lenders. In addition, Bunge's operating companies had $914 million and $546 million in short-term borrowings outstanding under local bank lines of credit at September 30, 2023, and December 31, 2022, respectively, to support working capital requirements. The original maturity of borrowings under uncommitted bilateral credit lines and local bank lines of credit varies based upon the Company's financing objectives. As a result, proceeds and repayments of such credit lines may be presented on a net basis, or separately, in the condensed consolidated statements of cash flows as dictated by the borrowing's original maturity.

The fair value of Bunge’s long-term debt, including current portion, is calculated based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. The carrying amounts and fair values of long-term debt are as follows:


	September 30, 2023				December 31, 2022
(US$ in millions)	Carrying Value		Fair Value (Level 2)			Carrying Value		Fair Value (Level 2)
Long-term debt, including current portion	$	4,268	$	4,294		$	4,105	$	4,148

Upon maturity in June 2023, Bunge repaid the principal and accrued interest due on its issued and outstanding 800 million Euro 1.85% Senior Notes.

On August 5, 2022, Bunge entered into an unsecured $250 million delayed draw term loan (the "$250 Million February 2023 Delayed Draw Term Loan") with a group of lenders that was required to be drawn by February 2, 2023. The $250 million February 2023 Delayed Draw Term Loan bears interest at SOFR plus a SOFR adjustment and applicable margin, as defined in the $250 million February 2023 Delayed Draw Term Loan agreement. The $250 million February 2023 Delayed Draw Term Loan was drawn on February 2, 2023 and matures on August 5, 2027.

On July 26, 2022, and later amended on October 7, 2022, Bunge entered into an unsecured $750 million delayed draw term loan (the "$750 Million Delayed Draw Term Loan") with a group of lenders giving Bunge the option to draw the loan by January 25, 2023. The $750 Million Delayed Draw Term Loan bears interest at SOFR plus a SOFR adjustment and applicable margin, as defined in the $750 Million Delayed Draw Term Loan agreement. The $750 Million Delayed Draw Term Loan was drawn on January 25, 2023 and matures on October 24, 2025.

On October 6, 2023, Bunge prepaid and terminated its 5-year term loan agreement due 2024, dated as of July 1, 2019, as amended as of December 15, 2021, as further amended as of June 21, 2023, with Sumitomo Mitsui Banking Corporation, as administrative agent, and certain lenders party thereto. On September 30, 2023, term loans in the amount of ¥30.7 billion and $90 million, for a total of $296 million, were recorded in Current portion of long-term debt on the condensed consolidated balance sheet. The Company does not expect to pay any prepayment penalties in connection with the termination.

Table of Contents

14. RELATED PARTY TRANSACTIONS

Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties. Such related party purchases comprised approximately 8% or less of total Cost of goods sold for the three and nine months ended September 30, 2023, and 2022. Bunge also sells agricultural commodity products to certain of its unconsolidated investees and other related parties. Such related party sales comprised approximately 2% or less of total Net sales for the three and nine months ended September 30, 2023, and 2022.

In addition, Bunge receives services from and provides services to its unconsolidated investees and other related parties, including tolling, port handling, administrative support, and other services. For the three and nine months ended September 30, 2023, and 2022, such services were not material to the Company's consolidated results.

At September 30, 2023, and December 31, 2022, receivables related to the above related party transactions comprised approximately 1% or less of total Trade accounts receivable. At September 30, 2023, and December 31, 2022, payables related to the above related party transactions comprised approximately 4% or less of total Trade accounts payable.

Bunge believes all transaction values to be similar to those that would be conducted with third parties at arm's-length.

15. COMMITMENTS AND CONTINGENCIES

Bunge is party to claims and lawsuits, primarily non-income tax and labor claims in South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates and inherent uncertainties. Bunge records liabilities related to legal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations, or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period in which the uncertainties are resolved should the liability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Information regarding the claims appears in Bunge’s Report on Form 10-K for the year ended December 31, 2022. Included in Other non-current liabilities as of September 30, 2023, and December 31, 2022, are the following amounts related to these matters:


(US$ in millions)	September 30, 2023		December 31, 2022
Non-income tax claims	$	19	$	20
Labor claims	69		76
Civil and other claims	109		105
Total	$	197	$	201

Brazil Indirect Taxes - non-income tax claims - These tax claims relate to claims against Bunge’s Brazilian subsidiaries, primarily value-added tax claims (ICMS, ISS, IPI and PIS/COFINS).

The Company continues to evaluate the merits of outstanding claims from examinations of ICMS and PIS/COFINS tax returns concluded by Brazilian federal and state tax authorities and will recognize them if and when loss is considered probable. The outstanding claims comprise the following:


(US$ in millions)	Years Examined	September 30, 2023		December 31, 2022
ICMS	1990 to Present	$	224	$	215
PIS/COFINS	2002 to Present	$	423	$	347

Table of Contents

Labor claims — The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.

Civil and other claims — The civil and other claims relate to various disputes with third parties, including suppliers and customers.

Guarantees — Bunge has issued or was a party to the following guarantees at September 30, 2023:


(US$ in millions)	Recorded Liability		Maximum Potential Future Payments
Unconsolidated affiliates guarantee (1)	$	—	$	93
Residual value guarantee (2)	—		388
Russia disposition indemnity (3)	9		235
Other guarantees	—		10
Total	$	9	$	726

(1) Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, certain Bunge subsidiaries have guaranteed the obligations of certain of their unconsolidated affiliates and in connection therewith have secured their guarantee obligations through a pledge to the financial institutions of certain of their unconsolidated affiliates' shares plus loans receivable from the unconsolidated affiliates in the event that the guaranteed obligations are enforced. Based on amounts drawn under such debt facilities at September 30, 2023, Bunge's potential liability was $58 million, and it has recorded less than $1 million obligation related to these guarantees within Other non-current liabilities.

(2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2024 through 2029. At September 30, 2023, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations.

(3) On February 3, 2023, Bunge agreed to indemnify the buyer of its Russian operations against certain existing legal claims involving Bunge's Russian subsidiary. The indemnity expires on February 2, 2030. As of September 30, 2023, Bunge recorded a $9 million obligation related to this indemnity within Other non-current liabilities.

Bunge Limited has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. ("BNA"), an indirect wholly-owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.

16. OTHER NON-CURRENT LIABILITIES

Other non-current liabilities consist of the following:


(US$ in millions)	September 30, 2023		December 31, 2022
Labor, legal, and other provisions	$	215	$	205
Pension and post-retirement obligations	146		152
Uncertain income tax positions (1)	64		59
Unrealized losses on derivative contracts, at fair value (2)	364		332
Other	111		101
Total	$	900	$	849

(1)See Note 9 - Income Taxes.

(2)See Note 11- Fair Value Measurements.

Table of Contents

17. EQUITY

Share repurchase program — As noted in Note 2 - Acquisitions and Dispositions, on June 12, 2023, Bunge's Board of Directors approved the expansion of an existing $500 million program for the repurchase of Bunge’s issued and outstanding common shares. At the time, approximately $300 million of capacity for the repurchase of Bunge common shares remained available under the existing program and Bunge's Board of Directors approved the expansion of the program by an additional $1.7 billion, for an aggregate unutilized capacity of $2.0 billion at June 12, 2023. The program continues to have an indefinite term. During the three and nine months ended September 30, 2023, Bunge repurchased 4,327,536 common shares for $488 million. As of September 30, 2023, 6,436,651 common shares were repurchased for $688 million and $1.5 billion remained outstanding for repurchases under the program.

In October 2023, Bunge repurchased an additional 1,080,325 common shares for $112 million. Therefore, as of October 26, 2023, 7,516,976 common shares were repurchased for $800 million and $1.4 billion remains outstanding for repurchases under the program.

Dividends on common shares — On August 17, 2023, Bunge announced that the Company's Board of Directors had declared a dividend of $0.6625 per common share, payable on December 1, 2023, to shareholders of record on November 17, 2023. During the nine months ended September 30, 2023, the Company's Board of Directors declared total dividends on common shares of $1.95 per common share.

Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of Accumulated other comprehensive income (loss) attributable to Bunge:



(US$ in millions)	Foreign Exchange Translation Adjustment		Deferred Gains (Losses) on Hedging Activities		Pension and Other Postretirement Liability Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance, July 1, 2023	$	(5,554)	$	(435)	$	(102)	$	(6,091)
Other comprehensive income (loss) before reclassifications	(162)		31		—		(131)

Amount reclassified from accumulated other comprehensive income (loss)	(1)		(1)		—		(2)
Balance, September 30, 2023	$	(5,717)	$	(405)	$	(102)	$	(6,224)



(US$ in millions)	Foreign Exchange Translation Adjustment		Deferred Gains (Losses) on Hedging Activities		Pension and Other Postretirement Liability Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance, July 1, 2022	$	(5,962)	$	(331)	$	(143)	$	(6,436)
Other comprehensive income (loss) before reclassifications	(333)		32		—		(301)
Acquisition of redeemable noncontrolling interest	(15)		—		—		(15)
Amount reclassified from accumulated other comprehensive income (loss)	158		(18)		1		141
Balance, September 30, 2022	$	(6,152)	$	(317)	$	(142)	$	(6,611)

Table of Contents



(US$ in millions)	Foreign Exchange Translation Adjustment		Deferred Gains (Losses) on Hedging Activities		Pension and Other Postretirement Liability Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance, January 1, 2023	$	(5,926)	$	(343)	$	(102)	$	(6,371)
Other comprehensive income (loss) before reclassifications	107		(61)		—		46

Amount reclassified from accumulated other comprehensive income (loss)	102		(1)		—		101
Balance, September 30, 2023	$	(5,717)	$	(405)	$	(102)	$	(6,224)



(US$ in millions)	Foreign Exchange Translation Adjustment		Deferred Gains (Losses) on Hedging Activities		Pension and Other Postretirement Liability Adjustments (1)		Accumulated Other Comprehensive Income (Loss)
Balance, January 1, 2022	$	(6,093)	$	(254)	$	(124)	$	(6,471)
Other comprehensive income (loss) before reclassifications	(202)		(38)		—		(240)
Acquisition of redeemable noncontrolling interest	(15)		—		—		(15)
Amount reclassified from accumulated other comprehensive income (loss) (1)	158		(25)		(18)		115
Balance, September 30, 2022	$	(6,152)	$	(317)	$	(142)	$	(6,611)

(1)On February 28, 2022, the Company, together with plan participants and related employee unions, agreed to the transition of one of the Company's international defined benefit pension plans to a multi-employer pension plan. Following the transition, the Company accounts for the multi-employer plan similar to a defined contribution plan, resulting in full settlement of the related defined benefit plan obligations.

In connection with the settlement, during the nine months ended September 30, 2022, the Company reclassified $27 million (net of $10 million tax expense) in unamortized actuarial gains from Accumulated other comprehensive income (loss), of which $19 million was attributable to Bunge (net of $7 million in tax expense), and $8 million was attributable to redeemable non-controlling interest (net of $3 million in tax expense).

18. EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per common share.


	Three Months Ended September 30,				Nine Months Ended September 30,
(US$ in millions, except for share data)	2023		2022		2023		2022







Net income (loss) attributable to Bunge common shareholders	$	373	$	380	$	1,627	$	1,274



Weighted-average number of common shares outstanding:
Basic	149,195,908		150,560,803		149,958,262		148,321,921
Effect of dilutive shares:
—stock options and awards (2)	2,020,948		1,859,490		1,933,552		2,562,862
—convertible preference shares (1)	—		—		—		2,629,703
Diluted	151,216,856		152,420,293		151,891,814		153,514,486

Earnings per common share:


Net income (loss) attributable to Bunge common shareholders—basic	$	2.50	$	2.52	$	10.85	$	8.59




Net income (loss) attributable to Bunge common shareholders—diluted	$	2.47	$	2.49	$	10.71	$	8.30

Table of Contents

(1) Effective March 23, 2022, (the "Conversion Date"), in accordance with the terms of the certificate of designation governing the convertible preference shares, all of the Company's issued and outstanding convertible preference shares were automatically converted into 1.2846 common shares of the Company, par value $0.01 per share. As a result of this conversion, dividends on the convertible preference shares ceased to accrue on the Conversion Date.

(2) The weighted-average common shares outstanding-diluted exclude less than one million stock options and contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for each of the three and nine months ended September 30, 2023, and 2022.

19. SEGMENT INFORMATION

The Company's operations are organized, managed, and classified into four reportable segments - Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy, based upon their similar economic characteristics, products and services offered, production processes, types and classes of customer, and distribution methods. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other.

The Agribusiness segment is characterized by both inputs and outputs being agricultural commodities and thus high volume and low margin. The Refined and Specialty Oils segment involves the processing, production, and marketing of products derived from vegetable oils. The Milling segment involves the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy reportable segment primarily comprises the net earnings in the Company’s 50% interest in BP Bunge Bioenergia, a joint venture with BP p.l.c. ("BP").

Corporate and Other includes salaries and overhead for corporate functions that are not allocated to the Company’s individual reporting segments because the operating performance of each reporting segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities, securitization program, and certain income tax assets and liabilities.

Transfers between segments are generally valued at market. Segment revenues generated from these transfers are shown in the following table as “Inter-segment revenues.”


	Three Months Ended September 30, 2023
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Eliminations		Total
Net sales to external customers	$	10,082	$	3,601	$	479	$	56	$	9	$	—	$	14,227
Inter–segment revenues	2,139		45		—		—		—		(2,184)		—
Cost of goods sold	(9,437)		(3,249)		(429)		(54)		(13)		—		(13,182)
Gross profit	645		352		50		2		(4)		—		1,045
Selling, general and administrative expenses	(145)		(98)		(25)		(1)		(178)		—		(447)
Foreign exchange (losses) gains	(52)		(2)		—		1		6		—		(47)
EBIT attributable to noncontrolling interests (1)	(9)		(6)		—		—		1		—		(14)
Other income (expense) - net	36		(19)		(2)		—		(7)		—		8
Income (loss) from affiliates	(14)		—		—		53		—		—		39
Total Segment EBIT (2)	461		227		23		55		(182)		—		584

Total assets	16,660		3,849		972		469		3,183		—		25,133

Table of Contents


	Three Months Ended September 30, 2022
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Eliminations		Total
Net sales to external customers	$	11,741	$	4,302	$	631	$	74	$	11	$	—	$	16,759
Inter–segment revenues	2,520		54		13		—		—		(2,587)		—
Cost of goods sold	(11,109)		(4,070)		(586)		(72)		(34)		—		(15,871)
Gross profit	632		232		45		2		(23)		—		888
Selling, general and administrative expenses	(135)		(86)		(26)		—		(90)		—		(337)
Foreign exchange (losses) gains	(35)		(6)		—		—		(11)		—		(52)
EBIT attributable to noncontrolling interests (1)	3		(3)		(1)		—		—		—		(1)
Other income (expense) - net	6		(9)		1		2		40		—		40
Income (loss) from affiliates	10		—		—		20		—		—		30
Total Segment EBIT (2)	481		128		19		24		(84)		—		568

Total assets	17,193		4,190		1,058		360		1,991		—		24,792



	Nine Months Ended September 30, 2023
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Eliminations		Total
Net sales to external customers	$	31,809	$	11,090	$	1,484	$	192	$	29	$	—	$	44,604
Inter–segment revenues	6,294		138		164		—		—		(6,596)		—
Cost of goods sold	(29,359)		(10,063)		(1,363)		(188)		(40)		—		(41,013)
Gross profit	2,450		1,027		121		4		(11)		—		3,591
Selling, general and administrative expenses	(428)		(291)		(70)		(1)		(430)		—		(1,220)
Foreign exchange (losses) gains	(77)		8		(1)		1		5		—		(64)
EBIT attributable to noncontrolling interests (1)	(29)		(17)		1		—		2		—		(43)
Other income (expense) - net	54		(50)		(5)		2		34		—		35
Income (loss) from affiliates	(19)		—		—		119		(17)		—		83
Total Segment EBIT (2)	1,951		677		46		125		(417)		—		2,382

Total assets	16,660		3,849		972		469		3,183		—		25,133



	Nine Months Ended September 30, 2022
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Eliminations		Total
Net sales to external customers	$	35,719	$	12,723	$	1,911	$	195	$	24	$	—	$	50,572
Inter–segment revenues	7,899		252		480		—		—		(8,631)		—
Cost of goods sold	(33,907)		(11,904)		(1,669)		(189)		(39)		—		(47,708)
Gross profit	1,812		819		242		6		(15)		—		2,864
Selling, general and administrative expenses	(375)		(262)		(78)		(1)		(263)		—		(979)
Foreign exchange (losses) gains	(119)		(14)		2		—		(19)		—		(150)
EBIT attributable to noncontrolling interests (1)	(14)		(7)		(1)		—		(11)		—		(33)
Other income (expense) - net	(71)		(17)		2		2		71		—		(13)
Income (loss) from affiliates	41		—		(1)		56		(1)		—		95
Total Segment EBIT (2)	1,274		519		166		63		(238)		—		1,784

Total assets	17,193		4,190		1,058		360		1,991		—		24,792

Table of Contents

(1) Include noncontrolling interests' share of interest and tax with EBIT attributable to noncontrolling interests in order to reconcile to consolidated Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests.

(2) Total Segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes Total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to Net income (loss) attributable to Bunge in the table below.

A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(US$ in millions)	2023		2022		2023		2022
Net income (loss) attributable to Bunge	$	373	$	380	$	1,627	$	1,274
Interest income	(38)		(30)		(121)		(50)
Interest expense	133		103		374		306
Income tax expense (benefit)	114		113		495		257

Noncontrolling interests' share of interest and tax	2		2		7		(3)
Total Segment EBIT	$	584	$	568	$	2,382	$	1,784

The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging (ASC 815) and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts with Customers (ASC 606). The following tables provide a disaggregation of Net sales to external customers between sales from commodity contracts (ASC 815) and sales from contracts with customers (ASC 606):


	Three Months Ended September 30, 2023
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Total
Sales from commodity contracts (ASC 815)	$	9,491	$	305	$	23	$	53	$	—	$	9,872
Sales from contracts with customers (ASC 606)	591		3,296		456		3		9		4,355
Net sales to external customers	$	10,082	$	3,601	$	479	$	56	$	9	$	14,227


	Three Months Ended September 30, 2022
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Total
Sales from commodity contracts (ASC 815)	$	10,900	$	333	$	26	$	72	$	—	$	11,331
Sales from contracts with customers (ASC 606)	841		3,969		605		2		11		5,428
Net sales to external customers	$	11,741	$	4,302	$	631	$	74	$	11	$	16,759

Table of Contents



	Nine Months Ended September 30, 2023
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Total
Sales from commodity contracts (ASC 815)	$	30,073	$	745	$	138	$	187	$	—	$	31,143
Sales from contracts with customers (ASC 606)	1,736		10,345		1,346		5		29		13,461
Net sales to external customers	$	31,809	$	11,090	$	1,484	$	192	$	29	$	44,604



	Nine Months Ended September 30, 2022
(US$ in millions)	Agribusiness		Refined and Specialty Oils		Milling		Sugar and Bioenergy		Corporate and Other		Total
Sales from commodity contracts (ASC 815)	$	33,396	$	963	$	135	$	191	$	—	$	34,685
Sales from contracts with customers (ASC 606)	2,323		11,760		1,776		4		24		15,887
Net sales to external customers	$	35,719	$	12,723	$	1,911	$	195	$	24	$	50,572

Table of Contents

Cautionary Statement Regarding Forward Looking Statements

This report contains both historical and forward looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. These factors include the risks, uncertainties, trends and other factors described in our Form 10-K, Form 10-Q, and Form 8-K reports (including all amendments to those reports) and include: the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on Bunge resulting from the continuation and/or escalation of the war and sanctions against Russia; the effect of weather conditions and the impact of crop and animal disease on our business; the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; changes in governmental policies and laws affecting our business, including agricultural and trade policies, financial markets regulation and environmental, tax and biofuels regulation; the impact of seasonality; the impact of government policies and regulations; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances, including without limitation Bunge's proposed business combination with Viterra Limited, and the Company's ability to consummate the proposed redomestication that would change the Company's place of incorporation and residence from Bermuda to Switzerland; the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries; the effectiveness of our capital allocation plans, funding needs and financing sources; the effectiveness of our risk management strategies; operational risks, including industrial accidents, natural disasters, pandemics or epidemics and cybersecurity incidents; changes in foreign exchange policy or rates; the impact of our dependence on third parties; our ability to attract and retain executive management and key personnel; and other factors affecting our business generally.

The forward looking statements included in this report are made only as of the date of this report, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.

You should refer to “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 24, 2023, “Risks Related to the Acquisition” and “Risks Related to the Redomestication” sections of the Company's definitive proxy statement filed with the SEC on August 7, 2023, and “Part II — Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of these factors.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Third Quarter 2023 Overview

You should refer to "Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting Operating Results" in our Annual Report on Form 10-K for the year ended December 31, 2022, for a discussion of key factors affecting operating results in each of our business segments. In addition, you should refer to "Item 9A, Controls and Procedures" in our Annual Report on Form 10-K for the year ended December 31, 2022, and to "Item 4, Controls and Procedures" in this Quarterly Report on Form 10-Q for the period ended September 30, 2023, for a discussion of our internal controls over financial reporting.

Non-U.S. GAAP Financial Measures

Total segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge also uses Core Segment EBIT, Non-core Segment EBIT, Corporate and Other EBIT, and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-core reportable segments, and Total reportable segments together with Corporate and Other. Core Segment EBIT is the aggregate of the EBIT of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core Segment EBIT is the EBIT of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the EBIT of Bunge’s Core and Non-core reportable segments, together with Corporate and Other. Bunge’s management believes Core Segment EBIT, Non-core Segment EBIT, and Total Segment EBIT are useful measures of operating profitability since the measures allow for an evaluation of the performance of its segments without regard to financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-U.S. GAAP financial measure and is not intended to replace Net income attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT excludes EBIT attributable to noncontrolling interests and is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Net income attributable to Bunge to Total Segment EBIT below.

Cash provided by (used for) operating activities, adjusted is calculated by including the Proceeds from beneficial interests in securitized trade receivables with Cash provided by (used for) operating activities. Cash provided by (used for) operating activities, adjusted is a non-U.S. GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable U.S. GAAP financial measure. Our management believes presentation of this measure allows investors to view our cash generating performance using the same measure that management uses in evaluating financial and business performance and trends.

Executive Summary

Net Income (Loss) Attributable to Bunge - For the three months ended September 30, 2023, Net income attributable to Bunge was $373 million, a decrease of $7 million compared to $380 million for the three months ended September 30, 2022. For the nine months ended September 30, 2023, Net income attributable to Bunge was $1,627 million, an increase of $353 million, compared to $1,274 million for the nine months ended September 30, 2022. The decrease for the three months ended September 30, 2023, was due to lower results in Corporate and Other, as further discussed in the Segment Overview & Results of Operations section below, as well as higher interest expense, as discussed further in the Interest section below, partially offset by higher Segment EBIT in our Core and Non-core segments as discussed in the Segment Overview & Results of Operations section below. The increase for the nine months ended September 30, 2023 was due to higher Segment EBIT in our Core and Non-core segments, partially offset by lower EBIT in our Corporate and Other activities, as further discussed in the Segment Overview & Results of Operations section below and higher income tax expense as discussed further below.

Earnings Per Common Share - Diluted - For the three months ended September 30, 2023, Net income attributable to Bunge common shareholders, diluted, was $2.47 per share, a decrease of $0.02 per share, compared to income of $2.49 per share for the three months ended September 30, 2022. For the nine months ended September 30, 2023, Net income attributable to Bunge common shareholders, diluted, was $10.71 per share, an increase of $2.41 per share, compared to income of $8.30 per share for the nine months ended September 30, 2022.

EBIT - For the three months ended September 30, 2023, Total Segment EBIT was $584 million, an increase of $16 million compared to Total Segment EBIT of $568 million for the three months ended September 30, 2022. For the nine months ended September 30, 2023, Total Segment EBIT was $2,382 million, an increase of $598 million compared to Total Segment EBIT of $1,784 million for the nine months ended September 30, 2022. The increase in Total Segment EBIT for

Table of Contents

the three and nine months ended September 30, 2023, was due to higher Segment EBIT in our Core and Non-core segments, partially offset by lower Segment EBIT in our Corporate and Other activities, as further discussed in the Segment Overview & Results of Operations section below.

Income Tax (Expense) Benefit - Income tax expense was $114 million for the three months ended September 30, 2023 compared to $113 million for the three months ended September 30, 2022. Income tax expense was $495 million for the nine months ended September 30, 2023 compared to $257 million for the nine months ended September 30, 2022. The increase was primarily due to higher pre-tax income in 2023, as well as an unfavorable earnings mix in 2023.

Liquidity and Capital Resources – At September 30, 2023, working capital, which equals Total current assets less Total current liabilities, was $8,379 million, an increase of $1,751 million, compared to working capital of $6,628 million at September 30, 2022, and an increase of $1,221 million, compared to working capital of $7,158 million at December 31, 2022. The increases in working capital at September 30, 2023, compared to September 30, 2022, and December 31, 2022, were primarily due to a higher Cash and cash equivalents balances as well as lower Short-term debt and Current portion of long-term debt balances, driven by strong operating cash flows.

Segment Overview & Results of Operations

Our operations are organized, managed and classified into four reportable segments based upon their similar economic characteristics, nature of products and services offered, production processes, types and classes of customer, and distribution methods. We further organize these reportable segments into Core operations and Non-core operations. Core operations comprise our Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core operations comprise our Sugar & Bioenergy segment, which itself primarily comprises the Company’s 50% interest in the net earnings of BP Bunge Bioenergia, a joint venture with BP p.l.c. ("BP").

Our remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other. Corporate and Other includes salaries and overhead for corporate functions that are not allocated to our individual reportable segments because the operating performance of each reportable segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities, securitization program, and certain income tax assets and liabilities.

Table of Contents

A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(US$ in millions)	2023		2022		2023		2022
Net income (loss) attributable to Bunge	$	373	$	380	$	1,627	$	1,274
Interest income	(38)		(30)		(121)		(50)
Interest expense	133		103		374		306
Income tax expense (benefit)	114		113		495		257

Noncontrolling interests' share of interest and tax	2		2		7		(3)
Total Segment EBIT	$	584	$	568	$	2,382	$	1,784

Agribusiness Segment EBIT	461		481		1,951		1,274
Refined and Specialty Oils Segment EBIT	227		128		677		519
Milling Segment EBIT	23		19		46		166
Core Segment EBIT	711		628		2,674		1,959

Corporate and Other EBIT	(182)		(84)		(417)		(238)

Sugar and Bioenergy Segment EBIT	55		24		125		63
Non-core Segment EBIT	55		24		125		63

Total Segment EBIT	$	584	$	568	$	2,382	$	1,784

Core Segments

Agribusiness Segment


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions, except volumes)	2023		2022		% Change		2023		2022		% Change
Volumes (in thousand metric tons)	18,854		19,622		(4)	%	55,497		59,182		(6)	%
Net sales	$	10,082	$	11,741	(14)	%	$	31,809	$	35,719	(11)	%
Cost of goods sold	(9,437)		(11,109)		(15)	%	(29,359)		(33,907)		(13)	%
Gross profit	645		632		2	%	2,450		1,812		35	%
Selling, general and administrative expense	(145)		(135)		7	%	(428)		(375)		14	%
Foreign exchange (losses) gains	(52)		(35)		(49)	%	(77)		(119)		35	%
EBIT attributable to noncontrolling interests	(9)		3		(400)	%	(29)		(14)		(107)	%
Other income (expense) – net	36		6		500	%	54		(71)		176	%
Income (loss) from affiliates	(14)		10		(240)	%	(19)		41		(146)	%
Total Agribusiness Segment EBIT	$	461	$	481	(4)	%	$	1,951	$	1,274	53	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Agribusiness segment Net sales decreased 14%, to $10,082 million for the three months ended September 30, 2023. The net decrease was primarily due to the following:

•In Processing, Net sales decreased 7%, primarily due to lower average sales prices experienced in almost all regions for our global soybean oilseed processing businesses and our Europe softseed business. Lower average sales prices resulted from a reduction of sales prices in the current year relative to the higher price environment in

Table of Contents

prior year following the onset of the Ukraine-Russia war. Also contributing to the decrease in Net sales was lower volumes resulting primarily from decreased sales in Argentina due to the drought experienced in the region in the current year. The above decreases were partially offset by higher volumes in our global soybean oilseed processing business as a result of strong demand in China and in the Europe softseed business despite the sale of our Russian Oilseed Processing business in the first quarter of 2023, as well as increased prices in our South America oilseed processing business driven by pressures from the lower supply as a result of the drought in Argentina.

•In Merchandising, Net sales decreased 29%, primarily due to lower average sales prices in our global corn, wheat, and oils businesses, resulting from a reduction of global commodity prices relative to the higher price environment in the prior year following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment. Volumes were also down slightly due to decreased demand in our global corn and oils businesses. Net sales were also down in our ocean freight business due to lower prices and stabilizing demand.

Cost of goods sold decreased 15%, to $9,437 million for the three months ended September 30, 2023. The net decrease was primarily due to the following:

•In Processing, Cost of goods sold decreased 8%, primarily due to lower sales, as noted in Net sales above, favorable mark-to-market results, a $4 million benefit in the three months ended September 30, 2023 from the recognition of mark-to-market gains related to the recovery of inventories in Ukraine, as well as an impairment charge of $21 million in the prior period related to the classification of our Russian oilseed processing business as held-for-sale.

•In Merchandising, Cost of goods sold decreased 29%, primarily due to the lower sales, as noted in Net sales above, and a $6 million benefit in the three months ended September 30, 2023 from the recognition of mark-to-market gains related to the recovery of inventories in Ukraine primarily from our Mykolaiv facility, partially offset by unfavorable mark-to-market results.

Foreign exchange (losses) gains - net decreased 49% to a loss of $52 million for the three months ended September 30, 2023. The current year increase in losses is primarily in Merchandising from current year losses in our Bunge Financial Services business partially offset by a reduction in losses in our Processing business on U.S. dollar-denominated loans payable in non-U.S. functional currency operations.

Other income (expense) - net was income of $36 million for the three months ended September 30, 2023, compared to income of $6 million for the three months ended September 30, 2022. The increase was primarily due to gains in Argentina related to foreign currency positioning.

Segment EBIT decreased 4%, to $461 million for the three months ended September 30, 2023. The net decrease was primarily due to the following:

•In Processing, an increase of 25% was primarily due to higher Gross profit, in part from improved margins in our Europe softseed business and global soybean oilseed processing business and higher Other income as described above.

•In Merchandising, a decrease of 77% was primarily due to lower Gross profit primarily driven by lower results in our ocean freight business and lower Foreign exchange results as described above.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Agribusiness segment Net sales decreased 11%, to $31,809 million for the nine months ended September 30, 2023. The net decrease was primarily due to the following:

•In Processing, Net sales decreased 3%, primarily due to lower average sales prices and lower volumes in the South America oilseed processing business. Lower volumes resulted primarily from reduced crush in Argentina due to the drought experienced in the region in the current year. Lower average sales prices and lower volumes in our European softseed processing business, resulted from a reduction of sales prices in the current year relative to the higher price environment in the prior year following the onset of the Ukraine-Russia war as well as lower volumes from the completion of the sale of our Russian Oilseed Processing business during the first quarter of 2023. The above decreases were partially offset by higher average sales prices and higher volumes in our global soybean oilseed processing businesses, and higher volumes in North America, as a result of strong protein and oil demand.

•In Merchandising, Net sales decreased 26%, primarily due to lower average sales prices in our global corn, oil, and wheat businesses, as a result of higher global commodity prices in the prior year following the onset of the

Table of Contents

Ukraine-Russia war, which exacerbated an already tight commodity supply environment. Volumes were also down slightly due to decreased demand in our global corn and oils businesses. Net sales were down in our ocean freight business due to lower prices and stabilizing demand. The above decreases were partially offset by higher sales volumes in our global wheat business, as a result of the partial resumption of operations in Ukraine.

Cost of goods sold decreased 13% to $29,359 million for the nine months ended September 30, 2023. The net decrease was primarily due to the following:

•In Processing, Cost of goods sold decreased 7%, primarily due to lower Net sales, favorable mark-to-market results, lack of recurring prior year losses in relation to the Ukraine-Russia war and impairment of the Russian business upon classification as held-for-sale, and an $18 million benefit in the nine months ended September 30, 2023 from the recognition of mark-to-market gains on the recovery of inventories in Ukraine. The decrease is partially offset by increased industrial costs, in particular labor and maintenance, during the current year.

•In Merchandising, Cost of goods sold decreased 27%, primarily due to lower Net sales, more favorable mark-to-market results, lack of recurring losses in relation to the Ukraine-Russia war and a $11 million benefit in the nine months ended September 30, 2023 from the recognition of mark-to-market gains related to the recovery of inventories in Ukraine primarily from our Mykolaiv facility.

SG&A increased 14% to $428 million for the nine months ended September 30, 2023. The increase was primarily driven by increased personnel costs and higher costs as a result of inflationary pressures, partially offset by favorable currency movements, primarily from the weakening Argentine peso.

Foreign exchange (losses) gains - net increased 35% to a loss of $77 million for the nine months ended September 30, 2023. The current year reduction in losses is primarily the result of less losses in our Processing business from a weakening U.S. dollar on U.S. dollar-denominated loans payable in non-U.S. functional currency operations. The impact was partially offset in Merchandising by a current year reduction in our Bunge Financial Services business.

Other income (expense) - net was income of $54 million for the nine months ended September 30, 2023 compared to expense of $71 million for the nine months ended September 30, 2022. The increase was primarily due to gains in Argentina related to foreign currency positioning compared to prior year losses on marketable securities and other short-term investments with exposures to Ukraine, following the onset of the Ukraine-Russia war.

Income (loss) from affiliates was loss of $19 million for the nine months ended September 30, 2023 compared to income of $41 million for the nine months ended September 30, 2022. The decrease was primarily due to results from equity method investments in South American resellers.

Segment EBIT increased 53% to $1,951 million for the nine months ended September 30, 2023. The net increase was primarily due to the following:

•In Processing, an increase of 82% was primarily due to higher Gross profit primarily driven by improved margins in our Europe softseed business, North America oilseed processing business, and our global soybean oilseed processing businesses, lower foreign exchange losses, and higher Other income (expense) - net, partially offset by higher SG&A as described above.

•In Merchandising, a decrease of 19% was primarily due lower Gross profit, driven by lower results in our ocean freight business, lower foreign exchange gains, higher SG&A, partially offset by higher Other income (expense) - net, as described above.

Table of Contents

Refined and Specialty Oils Segment


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions, except volumes)	2023		2022		% Change		2023		2022		% Change
Volumes (in thousand metric tons)	2,278		2,316		(2)	%	6,636		6,941		(4)	%
Net sales	$	3,601	$	4,302	(16)	%	$	11,090	$	12,723	(13)	%
Cost of goods sold	(3,249)		(4,070)		(20)	%	(10,063)		(11,904)		(15)	%
Gross profit	352		232		52	%	1,027		819		25	%
Selling, general and administrative expense	(98)		(86)		14	%	(291)		(262)		11	%
Foreign exchange (losses) gains	(2)		(6)		67	%	8		(14)		157	%
EBIT attributable to noncontrolling interests	(6)		(3)		(100)	%	(17)		(7)		(143)	%
Other income (expense) – net	(19)		(9)		(111)	%	(50)		(17)		(194)	%
Income (loss) from affiliates	—		—		—	%	—		—		—	%
Total Refined and Specialty Oils Segment EBIT	$	227	$	128	77	%	$	677	$	519	30	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Refined and Specialty Oils segment Net sales decreased 16%, to $3,601 million for the three months ended September 30, 2023. The decrease was primarily due to lower sales prices in all regions, driven by prices stabilizing and increased supply, including increased capacity in North America. Sales volumes were also lower in most regions, driven by the 2022 partial expiration of leased capacity at the Rotterdam facility as well as the sale of our Russian operations in the first quarter of 2023.

Cost of goods sold decreased 20%, to $3,249 million for the three months ended September 30, 2023. The decrease was primarily due to lower prices in all regions, as described for Net sales above, as well as effective management of supply chains, more favorable mark-to-market results, and an impairment charge of $55 million in the prior period related to the classification of our Russian oilseed and processing business as held-for-sale.

Segment EBIT increased 77% to $227 million for the three months ended September 30, 2023. The increase was due to higher Gross profit as described above.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Refined and Specialty Oils segment Net sales decreased 13% to $11,090 million for the nine months ended September 30, 2023, primarily due to lower average sales prices in most regions, driven by prices stabilizing and increased supply. Sales volumes were also lower in most regions, driven by the 2022 partial expiration of leased capacity at the Rotterdam facility as well as the sale of our Russian operations in the first quarter of 2023.

Cost of goods sold decreased 15% to $10,063 million for the nine months ended September 30, 2023. The decrease in Cost of goods sold was primarily due to lower average commodity prices and volumes in most regions, as described for Net sales above, favorable mark-to-market results, an impairment charge of $55 million in the prior period related to the classification of our Russian oilseed and processing business as held-for-sale, as well as effective management of supply chains.

Segment EBIT increased 30% to $677 million for the nine months ended September 30, 2023. The increase was due to higher Gross profit as described above.

Table of Contents

Milling Segment


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions, except volumes)	2023		2022		% Change		2023		2022		% Change
Volumes (in thousand metric tons)	890		1,234		(28)	%	2,555		3,537		(28)	%
Net sales	$	479	$	631	(24)	%	$	1,484	$	1,911	(22)	%
Cost of goods sold	(429)		(586)		(27)	%	(1,363)		(1,669)		(18)	%
Gross profit	50		45		11	%	121		242		(50)	%
Selling, general and administrative expense	(25)		(26)		(4)	%	(70)		(78)		(10)	%
Foreign exchange (losses) gains	—		—		—	%	(1)		2		(150)	%
EBIT attributable to noncontrolling interests	—		(1)		100	%	1		(1)		(200)	%
Other income (expense) – net	(2)		1		(300)	%	(5)		2		(350)	%
Income (loss) from affiliates	—		—		—	%	—		(1)		100	%
Total Milling Segment EBIT	$	23	$	19	21	%	$	46	$	166	(72)	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Milling segment Net sales decreased 24%, to $479 million for the three months ended September 30, 2023. The decrease was primarily due to lower volumes in our North American wheat milling business, driven by the completion of the sale of our Mexican wheat milling business in the third quarter of 2022. Net sales in the South America wheat milling business were relatively flat as lower volumes were largely offset by higher prices.

Cost of goods sold decreased 27%, to $429 million for the three months ended September 30, 2023. The decrease was primarily due to lower volumes, as described for Net sales above, due to the sale of our Mexican wheat milling business in the third quarter of 2022 as well as in South America a reduction due to lower raw material costs, partially offset by unfavorable mark-to-market results.

Segment EBIT increased 21%, to $23 million for the three months ended September 30, 2023. The increase was primarily due to higher Gross profit as described above.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Milling segment Net sales decreased 22% to $1,484 million for the nine months ended September 30, 2023. The decrease was primarily due to lower volumes in our North American wheat milling business, driven by the completion of the sale of our Mexican wheat milling business in the third quarter of 2022. Net sales in the South America wheat milling business were relatively flat as higher prices were largely offset by lower volumes.

Cost of goods sold decreased 18% to $1,363 million for the nine months ended September 30, 2023. The decrease was primarily due to lower volumes, as described for Net sales above, due to the sale of our Mexican wheat milling business in the third quarter of 2022, partially offset by unfavorable mark-to-market results compared to a strong prior year in South America during a period of high market volatility.

Segment EBIT decreased 72% to $46 million for the nine months ended September 30, 2023. The decrease was primarily due to lower Gross profit resulting from unfavorable mark-to-market in South America, as described above.

Table of Contents

Corporate and Other


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions)	2023		2022		% Change		2023		2022		% Change

Net sales	$	9	$	11	(18)	%	$	29	$	24	21	%
Cost of goods sold	(13)		(34)		(62)	%	(40)		(39)		3	%
Gross profit	(4)		(23)		(83)	%	(11)		(15)		(27)	%
Selling, general and administrative expense	(178)		(90)		98	%	(430)		(263)		63	%
Foreign exchange (losses) gains	6		(11)		155	%	5		(19)		126	%
EBIT attributable to noncontrolling interests	1		—		100	%	2		(11)		118	%
Other income (expense) – net	(7)		40		(118)	%	34		71		(52)	%
Income (loss) from affiliates	—		—		—	%	(17)		(1)		(1600)	%
Total Corporate and Other EBIT	$	(182)	$	(84)	(117)	%	$	(417)	$	(238)	(75)	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Corporate and Other EBIT decreased by 117%, to a loss of $182 million for the three months ended September 30, 2023. The decrease was primarily driven by increased SG&A expense, including $48 million related to acquisition and integration costs associated with the announced acquisition agreement with Viterra as well as increased expenses associated with other growth and productivity-related initiatives. Also contributing to the decrease was a $20 million impairment charge on a long-term investment partially offset by an impairment charge in the prior year of $11 million related to the classification of our Russian business as held-for-sale.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Segment EBIT decreased 75% to a loss of $417 million for the nine months ended September 30, 2023. The decrease was primarily driven by increased SG&A expense, including $66 million related to acquisition and integration costs associated with the announced acquisition agreement with Viterra as well as increased expenses associated with other growth and productivity-related initiatives and higher personnel costs. Also contributing to the decrease were impairment charges of $20 million, in Other income (expense) - net, related to a long-term investment, and $16 million, in Income (loss) from affiliates, related to a minority investment in Australian Plant Proteins, a start-up manufacturer of novel protein ingredients. In addition, results in the prior year included a gain of $29 million, at Bunge's then-70% share, related to the settlement of one of the Company's international defined benefit pension plans. The decreases described above were partially offset by an impairment charge in the prior year of $11 million related to the classification of our Russian business as held-for-sale.

Table of Contents

Non-core Segment

Sugar and Bioenergy Segment


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions)	2023		2022		% Change		2023		2022		% Change

Net sales	$	56	$	74	(24)	%	$	192	$	195	(2)	%
Cost of goods sold	(54)		(72)		(25)	%	(188)		(189)		(1)	%
Gross profit	2		2		—	%	4		6		(33)	%
Selling, general and administrative expense	(1)		—		(100)	%	(1)		(1)		—	%
Foreign exchange (losses) gains	1		—		100	%	1		—		100	%
EBIT attributable to noncontrolling interests	—		—		—	%	—		—		—	%
Other income (expense) – net	—		2		(100)	%	2		2		—	%
Income (loss) from affiliates	53		20		165	%	119		56		113	%
Total Sugar and Bioenergy Segment EBIT	$	55	$	24	129	%	$	125	$	63	98	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Segment EBIT increased 129%, to $55 million for the three months ended September 30, 2023. The increase was due to more favorable results from our investment in BP Bunge Bioenergia, primarily resulting from the non-recurrence of prior period foreign exchange losses on U.S. dollar denominated debt of the joint venture as well as higher sugar sales prices and volumes, partially offset by lower ethanol prices.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Segment EBIT increased 98% to $125 million for the nine months ended September 30, 2023. The increase was due to more favorable results from our investment in BP Bunge Bioenergia, primarily resulting from the release of a tax valuation allowance in the current period as well as higher sugar sales prices and lower foreign exchange losses on U.S. dollar denominated debt of the joint venture, partially offset by lower ethanol prices. The release of the tax valuation allowance is related to our investment in BP Bunge Bioenergia. Therefore, the tax valuation release is recorded within Income (loss) from affiliates and included in EBIT.

Interest - A summary of consolidated interest income and expense follows:


	Three Months Ended September 30,						Nine Months Ended September 30,
(US$ in millions)	2023		2022		% Change		2023		2022		% Change
Interest income	$	38	$	30	27	%	$	121	$	50	142	%
Interest expense	(133)		(103)		29	%	(374)		(306)		22	%

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Interest income increased 27%, to $38 million for the three months ended September 30, 2023. Interest expense increased by 29%, to $133 million for the three months ended September 30, 2023. The increase in net interest expense was due to higher variable interest rates on debt as well as $1 million in financing related fees associated with the announced acquisition agreement with Viterra in the current period, partially offset by higher interest income as a result of significantly higher investments in cash equivalents in the current year.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Interest income increased 142% to $121 million for the nine months ended September 30, 2023. Interest expense increased 22% to $374 million for the nine months ended September 30, 2023. Higher interest income is the result of significantly higher investments in cash equivalents in the current year. Higher interest expense is the result of higher variable interest rates on debt, as well as, $12 million in financing related fees associated with the announced acquisition agreement with Viterra in the current period. Partially offsetting the current period increase in interest expense is a prior year charge of $47 million resulting from the early redemption of all issued and outstanding 4.35% Senior Notes due March 2024.

Table of Contents

Liquidity and Capital Resources

Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength. We generally finance our ongoing operations with cash flows generated from operations, issuances of commercial paper, borrowings under various bilateral and syndicated revolving credit facilities, term loans, and proceeds from the issuance of senior notes. Acquisitions and long-lived assets are generally financed with a combination of equity and long-term debt.

Working Capital


	As of
US$ in millions, except current ratio	September 30, 2023		September 30, 2022		December 31, 2022
Cash and cash equivalents	$	2,173	$	956	$	1,104
Trade accounts receivable, net	2,509		2,336		2,829
Inventories	7,548		8,112		8,408
Other current assets(1)	4,394		5,791		4,417
Total current assets	$	16,624	$	17,195	$	16,758
Short-term debt	$	914	$	1,327	$	546
Current portion of long-term debt	301		773		846
Trade accounts payable	3,975		4,455		4,386
Current operating lease obligations	317		436		425
Other current liabilities(2)	2,738		3,576		3,397
Total current liabilities	$	8,245	$	10,567	$	9,600
Working capital(3)	$	8,379	$	6,628	$	7,158
Current ratio(4)	2.02		1.63		1.75

(1) Comprises Assets held for sale and Other current assets.

(2) Comprises Liabilities held for sale and Other current liabilities.

(3) Working capital is Total current assets less Total current liabilities.

(4) Current ratio represents Total current assets divided by Total current liabilities.

Working capital was $8,379 million at September 30, 2023, an increase of $1,221 million from working capital of $7,158 million at December 31, 2022, and an increase of $1,751 million from working capital of $6,628 million at September 30, 2022.

Cash and Cash Equivalents - Cash and cash equivalents were $2,173 million at September 30, 2023, an increase of $1,069 million from $1,104 million at December 31, 2022, and an increase of $1,217 million from $956 million at September 30, 2022. Cash balances are managed in accordance with our investment policy, the objectives of which are to preserve the principal value of our cash assets, maintain a high degree of liquidity, and deliver competitive returns subject to prevailing market conditions. Cash balances are typically invested in short-term deposits, money market funds, and commercial paper programs with highly-rated financial institutions and in U.S. government securities. Please refer to the Cash Flows section of this report, below, for details regarding the primary factors giving rise to the change in Cash and cash equivalents during the nine months ended September 30, 2023.

Trade accounts receivable, net - Trade accounts receivable, net were $2,509 million at September 30, 2023, a decrease of $320 million from $2,829 million at December 31, 2022, and an increase of $173 million from $2,336 million at September 30, 2022. The decrease from December 31, 2022, was primarily due to decreased Net sales in the current period driven by factors described in the Segment Overview & Results of Operations above. The increase from September 30, 2022, was primarily due to the change in the Trade Receivables Securitization Program structure, as described in Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program to our condensed consolidated financial statements, which results in inclusion of receivables pledged to the administrative agent in Trade accounts receivable.

Inventories - Inventories were $7,548 million at September 30, 2023, a decrease of $860 million from $8,408 million at December 31, 2022, and a decrease of $564 million from $8,112 million at September 30, 2022. The decrease from December 31, 2022 and September 30, 2022, was due to lower average commodity prices partially offset by higher volumes as of September 30, 2023.

Table of Contents

RMI comprise agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat that are readily convertible to cash because of their commodity characteristics, widely available markets and international pricing mechanisms. Total RMI reported at fair value was $6,172 million, $6,680 million, and $6,443 million at September 30, 2023, December 31, 2022, and September 30, 2022, respectively (see Note 5 - Inventories to our condensed consolidated financial statements).

Other current assets - Other current assets were $4,394 million at September 30, 2023, a decrease of $23 million from $4,417 million at December 31, 2022, and a decrease of $1,397 million from $5,791 million at September 30, 2022. The decrease from December 31, 2022, was primarily due a decrease in Assets held for sale due to the completion of the sale of our Russian operations in the first quarter of 2023. The decrease from September 30, 2022, was primarily due to significantly lower unrealized gains on derivative contracts, a decrease in deferred purchase price receivable as a result of restructuring our trade receivables securitization program during the fourth quarter of 2022 (see Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program to our condensed consolidated financial statements), a reduction in prepaid expenses, and a decrease in Assets held for sale due to the completion of the sale of our Russian operations in the first quarter of 2023.

Short-term debt - Short-term debt, including the Current portion of long-term debt, was $1,215 million at September 30, 2023, a decrease of $177 million from $1,392 million at December 31, 2022, and a decrease of $885 million from $2,100 million at September 30, 2022. The lower Short-term debt levels at September 30, 2023, compared to December 31, 2022 and September 30, 2022, were due to the repayment of 1.85% Senior Notes - Euro in June 2023 and higher working capital funding requirements in the prior year partially offset by higher borrowings by Bunge operating companies on local bank lines of credit.

Trade accounts payable - Trade accounts payable were $3,975 million at September 30, 2023, a decrease of $411 million from $4,386 million at December 31, 2022, and a decrease of $480 million from $4,455 million at September 30, 2022. The decrease from December 31, 2022 and September 30, 2022, was primarily due to lower average inventory prices during the current period.

Other current liabilities - Other current liabilities were $2,738 million at September 30, 2023, a decrease of $659 million from $3,397 million at December 31, 2022, and a decrease of $838 million from $3,576 million at September 30, 2022. The decrease from December 31, 2022, was primarily due to lower unrealized losses on derivative contracts and advances on sales during the current period. The decrease from September 30, 2022, was primarily due to significantly lower unrealized losses on derivative contracts.

Debt

Financing Arrangements and Outstanding Indebtedness - Prior to June 21, 2023, we conducted most of our third party financing activities through a centralized financing structure that provided the Company with efficient access to debt and capital markets. This structure included a master trust (the “Bunge Master Trust”), the primary assets of which comprised intercompany loans made to Bunge Limited and its subsidiaries. Certain of Bunge Limited’s 100% owned finance subsidiaries, including Bunge Limited Finance Corp., Bunge Finance Europe B.V., and Bunge Asset Funding Corp., funded the Bunge Master Trust with short and long-term debt obtained from third parties, including through our commercial paper program and certain credit facilities, as well as the issuance of senior notes. Borrowings by these finance subsidiaries carry full, unconditional guarantees by Bunge Limited.

On June 21, 2023, Bunge and its finance subsidiaries terminated the Bunge Master Trust in accordance with a termination and lien release agreement in order to simplify the legal framework around its capital structure (see Note 13 - Debt). In connection with the termination of the Bunge Master Trust, Bunge amended its existing credit agreements and related guarantees to remove all references and provisions related to the Bunge Master Trust. The amendments also provide, or additional amendments are expected to be entered into that will provide, that Bunge’s obligations as the existing guarantor will be automatically assigned to Bunge Global SA, the new Swiss holding company (“Bunge Global”), as successor guarantor, effective at the completion of the previously announced redomestication from Bermuda to Switzerland, which was approved by Bunge’s shareholders at the Extraordinary General Meeting held on October 5, 2023.

Revolving Credit Facilities - At September 30, 2023, we had $5,665 million unused and available committed borrowing capacity, comprised of committed revolving credit facilities. The following table summarizes these facilities as of the periods presented:

Table of Contents


(US$ in millions)		Total Committed Capacity (2)		Borrowings Outstanding
Revolving Credit Facilities(1)	Maturities	September 30, 2023		September 30, 2023		December 31, 2022
Revolving credit facilities
$1.1 Billion 364-day Revolving Credit Agreement	2024	$	1,100	$	—	$	—
$1.75 Billion 2024 Revolving Credit Facility	2026(3)	1,750		—		—
$1.95 Billion 5-year Revolving Credit Agreement	2026	1,950		—		—
$865 Million 2026 Revolving Credit Facility	2026	865		—		—
Total revolving credit facilities		$	5,665	$	—	$	—

(1)See Note 13 - Debt for further information on these programs.

(2)The short-term credit ratings of the new $1 Billion Commercial Paper Program (see Note 13 - Debt for further details on program) require Bunge to keep same day unused committed borrowing capacity under its long-term committed credit facilities in an amount greater or equal to the amount of commercial paper issued and outstanding.

(3)On October 6, 2023, Bunge entered into an unsecured $1.75 billion revolving credit facility ("$1.75 Billion Revolving Credit Facility"), with a group of lenders, maturing on October 6, 2026. The $1.75 Billion Revolving Credit Facility replaced the existing $1.75 billion facility, dated December 16, 2021, as amended on April 26, 2022, and as further amended and restated on June 21, 2023. See Note 13 - Debt for further details on program.

Short and long-term debt - Our short and long-term debt increased by $531 million to $5,182 million at September 30, 2023, from $4,651 million at December 31, 2022, primarily due to the draws on our $250 Million February 2023 Delayed Draw Term Loan and $750 Million Delayed Draw Term Loan offset by the repayment of the 1.85% Senior Notes - Euro in June 2023. For the nine months ended September 30, 2023, our average short and long-term debt outstanding was approximately $5,323 million, compared to approximately $6,240 million for the nine months ended September 30, 2022. Our Long-term debt balance, including the Current portion of long-term debt, was $4,268 million at September 30, 2023, an increase of $163 million, compared to $4,105 million at December 31, 2022. The increase was primarily due to the draws on our $250 Million February 2023 Delayed Draw Term Loan and $750 Million Delayed Draw Term Loan offset by the repayment of the 1.85% Senior Notes - Euro in June 2023.

The following table summarizes our short-term debt at September 30, 2023.


(US$ in millions)	Outstanding Balance at September 30, 2023		Weighted Average Interest Rate at September 30, 2023		Highest Balance Outstanding During Quarter Ended September 30, 2023		Average Balance During Quarter Ended September 30, 2023		Weighted Average Interest Rate During Quarter Ended September 30, 2023
Bank borrowings (1)	$	914	28.02	%	$	914	$	785	19.80	%
Commercial paper	—		—	%	80		20		5.50	%
Total	$	914			$	994	$	805

(1) Includes $321 million of local currency bank borrowings in certain Central and Eastern European, South American, and Asia-Pacific countries at a weighted average interest rate of 68.32% as of September 30, 2023.

From time to time, through our financing subsidiaries, we enter into bilateral short-term credit lines as necessary based on our financing requirements. At September 30, 2023, there were no borrowings outstanding under these bilateral short-term credit lines. In addition, Bunge's operating companies had $914 million and $546 million in short-term borrowings outstanding from local bank lines of credit at September 30, 2023, and December 31, 2022, respectively, to support working capital requirements.

On August 5, 2022, Bunge entered into an unsecured $250 million delayed draw term loan (the "$250 Million February 2023 Delayed Draw Term Loan") with a group of lenders that is required to be drawn by February 2, 2023. The $250 Million February 2023 Delayed Draw Term Loan will bear interest at SOFR plus a SOFR adjustment and applicable margin, as defined in the $250 Million February 2023 Delayed Draw Term Loan agreement. The $250 Million February 2023 Delayed Draw Term Loan was drawn on February 2, 2023 and matures on August 5, 2027.

Table of Contents

by January 25, 2023. The $750 Million Delayed Draw Term Loan will bear interest at SOFR plus a SOFR adjustment and applicable margin, as defined in the $750 Million Delayed Draw Term Loan agreement. The $750 Million Delayed Draw Term Loan was drawn on January 25, 2023 and matures on October 24, 2025.

As described in Note 2 - Acquisitions and Dispositions, Bunge has secured a total of $8.0 billion in Acquisition Financing in the form of a $7.7 billion financing commitment from a consortium of lenders, arranged by Sumitomo Mitsui Banking Corporation and a $300 million 5-year delayed draw term loan from CoBank and the U.S. farm credit system executed July 7, 2023 that may be drawn upon the closing of the acquisition. The commitment for the $7.7 billion financing commitment is in the form of a three tranche term loan maturing 364-days, 2-years and 3-years from closing of the acquisition. Bunge intends to use a portion of the Acquisition Financing to fund the cash portion of the Transaction Consideration, and the remainder for repayment of certain indebtedness of Viterra which is expected to be repaid at closing and for the ongoing operations of the combined company following closing.

The following table summarizes our short and long-term indebtedness:


(US$ in millions)	September 30, 2023		December 31, 2022
Short-term debt: (1)
Short-term debt (2)	$	914	$	546
Current portion of long-term debt	301		846
Total short-term debt	1,215		1,392
Long-term debt:


Term loan due 2024 - three-month TONAR plus 0.75% (Tranche A) (3)	206		232
Term loan due 2024 - three-month SOFR plus 1.40% (Tranche B) (3)	90		90
Term loan due 2025 - SOFR plus 0.90%	750		—
Term loan due 2027 - SOFR plus 1.125%	250		—
Term loan due 2028 - SOFR plus 1.325%	249		249
1.85% Senior Notes due 2023 - Euro(4)	—		853
1.63% Senior Notes due 2025	598		597
3.25% Senior Notes due 2026	698		698
3.75% Senior Notes due 2027	597		597
2.75% Senior Notes due 2031	991		990
Cumulative adjustment to long-term debt from application of hedge accounting	(363)		(341)
Other	202		140
Subtotal	4,268		4,105
Less: Current portion of long-term debt	(301)		(846)
Total long-term debt(5)	3,967		3,259
Total debt	$	5,182	$	4,651

(1) Includes secured debt of $106 million and $56 million at September 30, 2023, and December 31, 2022, respectively.

(2) Includes $321 million and $207 million of local currency borrowings in certain European, South American, and Asia-Pacific countries at a weighted average interest rate of 68.32% and 32.12% as of September 30, 2023, and December 31, 2022, respectively.

(3) On October 6, 2023, Bunge prepaid and terminated its 5-year term loan agreement due in 2024. See Note 13 - Debt for further details on the termination.

(4) Upon maturity in June 2023, Bunge repaid the principal and accrued interest due on all of the issued and outstanding 1.85% Senior Notes - Euro.

(5) Includes secured debt of $19 million and $21 million at September 30, 2023, and December 31, 2022, respectively.

Table of Contents

Credit Ratings — Bunge’s debt ratings and outlook by major credit rating agencies at September 30, 2023, were as follows:

Short-term

Debt (1)

Long-term
Debt

Outlook

Standard & Poor’s

A-2

BBB+

Positive

Moody’s

P-2

Baa2

Review for Upgrade

Fitch

BBB

Rating Watch Positive

(1) Short-term debt rating applies only to $1 Billion Commercial Paper Program with Bunge Limited Finance Corp. as the issuer.

Following the announcement of the Viterra acquisition, all three rating agencies reviewed our credit ratings and published updated credit opinions on us, reflecting their views of the credit profile of the company both on a current standalone basis, and a pro-forma at closing basis. Based on its review, Standard and Poor's upgraded our credit rating to BBB+ and further placed us on positive outlook for an upgrade to A-. Moody’s kept our credit rating unchanged at Baa2 and placed us on a review for upgrade to Baa1. Fitch kept our credit rating unchanged at BBB and placed us on credit watch positive for an upgrade to BBB+. We expect Standard and Poor's, Moody’s and Fitch to resolve their positive outlook, review for upgrade and credit watch positive status respectively at or before the closing date of the acquisition, based on a variety of factors including but not limited to our operating performance, our financial position and high certainty that the acquisition will close.

On June 21, 2023, we terminated our then existing $600 million asset-backed commercial paper program and the related liquidity and letter of credit facilities as well as established a new $1 billion unsecured corporate commercial paper program (the “$1 Billion Commercial Paper Program”). Standard & Poor’s and Moody’s assigned short-term ratings to the $1 Billion Commercial Paper Program of A-2 and P-2, respectively.

Our debt agreements do not have any credit rating downgrade triggers that would accelerate maturity of our debt. However, credit rating downgrades would increase borrowing costs under our syndicated credit facilities (a credit rating upgrade, on the other hand, would reduce our borrowing cost) and, depending on their severity, could impede our ability to obtain credit facilities or access the capital markets in the future on competitive terms. A significant increase in our borrowing costs could impair our ability to compete effectively in our business relative to competitors with higher credit ratings.

Our credit facilities and certain senior notes require us to comply with specified financial covenants including minimum current ratio, maximum debt to capitalization ratio and limitations on secured indebtedness. We were in compliance with these covenants as of September 30, 2023.

Equity

Total equity is set forth in the following table:


(US$ in millions)	September 30, 2023		December 31, 2022
Equity:

Common shares	$	1	$	1
Additional paid-in capital	6,727		6,692
Retained earnings	11,555		10,222
Accumulated other comprehensive income (loss)	(6,224)		(6,371)
Treasury shares, at cost; 2023 - 23,163,348 shares and 2022 - 18,835,812 shares	(1,808)		(1,320)
Total Bunge shareholders’ equity	10,251		9,224
Noncontrolling interest	892		732
Total equity	$	11,143	$	9,956

Table of Contents

Total Bunge shareholders’ equity was $10,251 million at September 30, 2023, compared to $9,224 million at December 31, 2022, an increase of $1,027 million. The increase was primarily due to $1,627 million of Net income attributable to Bunge, $147 million of Other comprehensive income, as described in Note 17 - Equity, $51 million of share-based compensation expense, partially offset by $488 million repurchases of common shares, as described in Note 17 - Equity, $290 million of declared dividends to common shareholders and $20 million from the issuance of common shares under our share based compensation programs.

Share repurchase program - As noted in Note 2 - Acquisitions and Dispositions, on June 12, 2023, Bunge's Board of Directors approved the expansion of an existing $500 million program for the repurchase of Bunge’s issued and outstanding common shares. At the time, approximately $300 million of capacity for the repurchase of Bunge common shares remained available under the existing program and Bunge's Board of Directors approved the expansion of the program by an additional $1.7 billion, for an aggregate unutilized capacity of $2.0 billion at June 12, 2023. The program continues to have an indefinite term. During the three and nine months ended September 30, 2023, Bunge repurchased 4,327,536 common shares for $488 million. As of September 30, 2023, 6,436,651 common shares were repurchased for $688 million and $1.5 billion remained outstanding for repurchases under the program.

Cash Flows


	Nine Months Ended September 30,
US$ in millions	2023		2022
Cash provided by (used for) operating activities	$	1,860	$	(5,031)
Cash provided by (used for) investing activities	(646)		5,113
Cash provided by (used for) financing activities	(213)		(102)
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale	40		112
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale	$	1,041	$	92

Our cash flows from operations vary depending on, among other items, the market prices and timing of purchases and sales of our inventories. Generally, during periods when commodity prices are rising, our Agribusiness operations require increased use of cash to support working capital to acquire inventories and fund daily settlement requirements on exchange traded futures that we use to minimize price risk related to purchases and sales of our inventories.

During the nine months ended September 30, 2023, our cash and cash equivalents, restricted cash, and cash held for sale increased by $1,041 million, compared to an increase of $92 million during the nine months ended September 30, 2022.

Operating: Cash provided by operating activities was $1,860 million for the nine months ended September 30, 2023, an increase of $6,891 million, compared to cash used for operating activities of $5,031 million for the nine months ended September 30, 2022. The increase was primarily due to net changes in working capital and decreased beneficial interest in securitized trade receivables, driven by lower average commodity prices as well a change in structure of the securitization program as discussed further below.


	Nine Months Ended September 30,
US$ in millions	2023		2022
Cash provided by (used for) operating activities	$	1,860	$	(5,031)
Proceeds from beneficial interest in securitized trade receivables (1)	85		5,176
Cash provided by (used for) operating activities, adjusted	$	1,945	$	145

Table of Contents

(1) On November 16, 2022, Bunge and certain of its subsidiaries amended its trade receivables securitization program from a deferred purchase price structure to a pledge structure, see Note 4 - Trade Accounts Receivable and Trade Receivables Securitization Program to our condensed consolidated financial statements for further details.

Cash provided by (used for) operating activities, adjusted for the proceeds from beneficial interests in securitized trade receivables, was cash provided of $1,945 million for the nine months ended September 30, 2023, compared to cash provided of $145 million for the nine months ended September 30, 2022. The increase was primarily due to net changes in working capital, driven by lower average commodity prices, and higher reported net income during the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022.

Certain of our non-U.S. operating subsidiaries are primarily funded with U.S. dollar-denominated debt, while currency risk is hedged with U.S. dollar-denominated assets. The functional currency of our operating subsidiaries is generally the local currency. The financial statements of our subsidiaries are calculated in the functional currency, and when the local currency is the functional currency, translated into U.S. dollars. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Also, certain of our U.S. dollar functional operating subsidiaries outside the U.S. are partially funded with local currency borrowings, while the currency risk is hedged with local currency denominated assets. Local currency loans in U.S. dollar functional currency subsidiaries outside the U.S. are remeasured into U.S. dollars at the exchange rate on the applicable balance sheet date. The resulting gain or loss is included in our condensed consolidated statements of income as Foreign exchange (losses) gains. We recorded a foreign currency gain on our debt of $151 million and $96 million, and for the nine months ended September 30, 2023 and September 30, 2022, respectively, which were included as adjustments to reconcile Net income to Cash provided by (used for) operating activities in the line item Foreign exchange (gain) loss on net debt in our condensed consolidated statements of cash flows. These adjustments are required as the gains and losses are non-cash items that arise from financing activities and therefore will have no impact on cash flows from operations.

Investing: Cash used for investing activities was $646 million for the nine months ended September 30, 2023, a decrease of $5,759 million, compared to cash provided by investing activities of $5,113 million for the nine months ended September 30, 2022. The decrease was primarily due to lower net proceeds from beneficial interests in securitized trade receivables as a result of the change in the program structure discussed above, and higher capital expenditures including the Avondale refinery. Additionally, lower proceeds were received on the sale of our Russian operations during the nine months ended September 30, 2023, compared to proceeds received on the sale of our Mexican wheat milling business during the nine months ended September 30, 2022.

Financing: Cash used for financing activities was $213 million for the nine months ended September 30, 2023, a decrease of $111 million, compared to cash used for financing activities of $102 million for the nine months ended September 30, 2022. During the nine months ended September 30, 2023, we received net cash proceeds of short and long-term debt of $512 million, primarily from delayed term draw loans of $750 million and $250 million offset by the repayment of the 1.85% Senior Notes - Euro in June 2023, repurchased $466 million of common shares and paid $287 million in dividends to common shareholders. During the nine months ended September 30, 2022, we made net cash repayments of short and long-term debt of $147 million, paid $256 million of dividend payments to common shareholders, repurchased $200 million of common shares, and paid $102 million to acquire an additional 10% ownership interest from redeemable noncontrolling interest holders in our subsidiary, Bunge Loders Croklaan Group B.V. These cash outflows were partially offset by $521 million in cash received from the sale of a noncontrolling interest in relation to the formation of a joint venture, Bunge Chevron Ag Renewables LLC, and $30 million in proceeds from the exercise of options for common shares.

Off-Balance Sheet Arrangements

Please refer to Note 15 - Commitments and Contingencies to our condensed consolidated financial statements for details concerning our off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Dividends

We paid a regular quarterly cash dividend of $0.6625 per share on September 1, 2023, to common shareholders of record on August 18, 2023. On August 17, 2023, Bunge announced that the Company's Board of Directors had declared a dividend of $0.6625 per common share, payable on December 1, 2023, to shareholders of record on November 17, 2023.

Table of Contents

Critical Accounting Policies and Estimates

Critical accounting policies are defined as those policies that are significant to our financial condition and results of operations and require management to exercise significant judgment. For a complete discussion of our accounting policies, see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on February 24, 2023. For recent accounting pronouncements refer to Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies, to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Risk Management

As a result of our global activities, we are exposed to changes in, among other things, agricultural commodity prices, transportation costs, foreign currency exchange rates, interest rates, energy costs, and inflationary pressures, which may affect our results of operations and financial position. We actively monitor and manage these various market risks associated with our business activities. Our risk management decisions take place in various locations, but exposure limits are centrally set and monitored, operating under a global governance framework. Additionally, our Board of Directors' Enterprise Risk Management Committee and our internal Management Risk Committee oversee our global market risk governance framework, including risk management policies and limits.

We use derivative instruments for the purpose of managing the exposures associated with commodity prices, transportation costs, foreign currency exchange rates, interest rates, energy costs, and for positioning our overall portfolio relative to expected market movements in accordance with established policies and procedures. We enter into derivative instruments primarily with commodity exchanges in the case of commodity futures and options and major financial institutions in the case of ocean freight. While these derivative instruments are subject to fluctuations in value, for hedged exposures those fluctuations are generally offset by the changes in the fair value of the underlying exposures. The derivative instruments that we use for hedging purposes are intended to reduce the volatility of our results of operations. However, they can occasionally result in earnings volatility, which may be material. See Note 12 - Derivative Instruments And Hedging Activities to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for a more detailed discussion of our use of derivative instruments.

Credit and Counterparty Risk

Through our normal business activities, we are subject to significant credit and counterparty risks that arise through commercial sales and purchases, including forward commitments to buy or sell, and through various other over-the-counter ("OTC") derivative instruments that we use to manage risks inherent in our business activities. We define credit and counterparty risk as a potential financial loss due to the failure of a counterparty to honor its obligations. The exposure is measured based upon several factors, including unpaid accounts receivable from counterparties, as well as unrealized gains from forward purchase or sales contracts and OTC derivative instruments. Credit and counterparty risk also includes sovereign credit risk. We actively monitor credit and counterparty risk through regular reviews of exposures and credit analysis by regional credit teams, as well as a review by global and corporate committees that monitor counterparty performance. We record provisions for counterparty losses from time to time as a result of our credit and counterparty analysis.

During periods of tight conditions in global credit markets, downturns in regional or global economic conditions, and/or significant price volatility, credit and counterparty risks are heightened, such as during 2023 when concerns about the financial condition of a number of banking institutions in the United States and globally developed and resulted in government and regulatory intervention. Although our counterparty risk and exposure to these financial institutions has been de minimis, we continue to monitor our exposure to all financial institution counterparties. This increased risk is monitored through, among other things, exposure reporting, increased communication with key counterparties, management reviews, and a specific focus on counterparties or groups of counterparties that we may determine as high risk. We have reduced exposures and associated position limits in certain cases.

Commodities Risk

We operate in many areas of the food industry, from agricultural raw materials to the production and sale of branded food products. As a result, we purchase and produce various materials, many of which are agricultural commodities, including: soybeans, soybean oil, soybean meal, palm oil (from crude to various degrees of refined products), softseeds (including sunflower seed, rapeseed and canola) and related oil and meal derived from them, wheat, barley, shea nut, and corn. Agricultural commodities are subject to price fluctuations due to a number of unpredictable factors, including inflationary pressures, that may create price risk. As described above, we are also subject to the risk of counterparty non-performance under forward purchase and sales contracts. From time to time, we have experienced instances of counterparty non-performance as a result of significant declines in counterparty profitability under these contracts due to movements in commodity prices between the time the contracts were entered into and the contractual forward delivery period.

We enter into various derivative contracts with the primary objective of managing our exposure to adverse price movements in the agricultural commodities used and produced in our business operations. We have established policies that limit the amount of unhedged fixed price agricultural commodity positions permissible for our operating companies, which are generally a combination of volumetric, drawdown, and value-at-risk ("VaR") limits. We measure and review our commodity

Table of Contents

positions on a daily basis. We also employ stress-testing techniques in order to quantify our exposures to price and liquidity risks under non-normal or event driven market conditions.

Our daily net agricultural commodity position consists of inventory, forward purchase and sales contracts, and OTC and exchange-traded derivative instruments, including those used to hedge portions of our production requirements. The fair value of that position is a summation of the fair values of each agricultural commodity, calculated by valuing all of our commodity positions for the period at quoted market prices, where available, or by utilizing a close proxy. VaR is calculated on the net position and monitored at the 95% confidence interval. In addition, scenario analysis and stress testing are performed. For example, one measure of market risk is estimated as the potential loss in fair value resulting from a hypothetical 10% adverse change in prices. The results of this analysis, which may differ from actual results, are as follows:


	Nine Months Ended September 30, 2023				Year Ended December 31, 2022
(US$ in millions)	Value		Market Risk		Value		Market Risk
Highest daily aggregated position value	$	459	$	(46)	$	1,809	$	(181)
Lowest daily aggregated position value	$	(377)	$	(38)	$	(416)	$	(42)

Ocean Freight Risk

Ocean freight represents a significant portion of our operating costs. The market price for ocean freight varies depending on the supply and demand for ocean vessels, global economic conditions, inflationary pressure, and other factors. We enter into time charter agreements for time on ocean freight vessels based on forecasted requirements for the purpose of transporting agricultural commodities. Our time charter agreements generally have terms ranging from two months to approximately five years. We use financial derivatives, generally freight forward agreements, to hedge portions of our ocean freight costs. The ocean freight derivatives are included in Other current assets and Other current liabilities on the condensed consolidated balance sheets at fair value.

Energy Risk

We purchase various energy commodities such as electricity, natural gas and bunker fuel, which are used to operate our manufacturing facilities and ocean freight vessels. These energy commodities are subject to price risk, including inflationary pressures. We use financial derivatives, including exchange traded and OTC swaps and options for various purposes, including to manage our exposure to volatility in energy costs and market prices. These energy derivatives are included in Other current assets and Other current liabilities on the condensed consolidated balance sheets at fair value.

Currency Risk

Our global operations require active participation in foreign exchange markets. Our primary foreign currency exposures are the Brazilian real, Canadian dollar, Euro, and Chinese yuan/renminbi. To reduce the risk arising from foreign exchange rate fluctuations, we enter into derivative instruments, such as foreign currency forward contracts, swaps and options. The changes in market value of such contracts have a high correlation to the price changes in the related currency exposures. The potential loss in fair value of such net currency positions resulting from a hypothetical 10% adverse change in foreign currency exchange rates as of September 30, 2023, was not material.

When determining our exposure, we exclude intercompany loans that are deemed to be permanently invested. Repayments of permanently invested intercompany loans are neither planned nor anticipated in the foreseeable future and are therefore treated analogous to equity for accounting purposes. As a result, the foreign exchange gains and losses on these borrowings are excluded from the determination of Net income (loss) and recorded as a component of Accumulated other comprehensive income (loss) in the condensed consolidated balance sheets. Included in Other comprehensive income (loss) are foreign exchange gains of $97 million for the nine months ended September 30, 2023, and foreign exchange gains of $1 million for the year ended December 31, 2022, related to permanently invested intercompany loans. Activity in the nine months ended September 30, 2023 includes reclassification of $85 million in foreign exchange losses from Other comprehensive income (loss) to net income, net of tax of zero, related to the sale of Bunge's Russian operations. See Note 2 - Acquisitions and Dispositions to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for more information.

Table of Contents

Interest Rate Risk

We have debt in fixed and floating rate instruments. We are exposed to market risk due to changes in interest rates, including inflationary pressures. We may enter into interest rate swap agreements to manage our interest rate exposure related to our debt portfolio.

The aggregate fair value of our short and long-term debt, based on market yields at September 30, 2023, was $5,208 million, with a carrying value of $5,182 million.

A hypothetical 100 basis point increase or decrease in the interest yields on our fixed rate debt and related interest rate swaps at September 30, 2023, would result in a less than 1% change in the fair value of our debt and interest rate swaps.

A hypothetical 100 basis point change in the applicable reference rate, such as SOFR, would result in a change of approximately $55 million in interest expense on our variable rate debt at September 30, 2023. Some of our variable rate debt is denominated in currencies other than in U.S. dollars and is indexed to non-U.S. dollar-based interest rate indices, such as EURIBOR and TLP, and certain benchmark rates in local bank markets. As such, the hypothetical 100 basis point change in interest rate ignores the potential impact of any currency movements. See Part I, “Item 1A. Risk Factors” in our 2022 Annual Report on Form 10-K for a discussion of certain risks related to interest rates.

Inflation Risk

Inflationary factors generally affect us by increasing our labor and overhead costs, as well as costs associated with certain risks identified above, which may adversely affect our results of operations and financial position. We have historically been able to recover the impacts of inflation through sales price increases, however we cannot reasonably estimate our ability to successfully recover any impact of inflation through price increases in the future. Our inability to do so could harm our results of operations and financial position.

Derivative Instruments

Foreign Exchange Derivatives—We use a combination of foreign exchange forward, swap, futures and options contracts in certain of our operations to mitigate the risk of exchange rate fluctuations in connection with certain commercial and balance sheet exposures. The foreign exchange forward swap and option contracts may be designated as cash flow hedges or fair value hedges. We may also use net investment hedges to partially offset the translation adjustments arising from the remeasurement of our investment in certain of our foreign subsidiaries.

We assess, both at the inception of the hedge and on an ongoing basis, whether the derivatives that are used in hedge transactions are highly effective in offsetting changes in the hedged items.

Interest Rate Derivatives—We may enter into interest rate swap agreements for the purpose of managing certain of our interest rate exposures. Interest rate swaps used by us as hedging instruments are recorded at fair value in the consolidated balance sheets with changes in fair value recorded contemporaneously in earnings. Certain of these agreements may be designated as fair value hedges. In such instances, the carrying amount of the associated hedged debt is also adjusted through earnings for changes in fair value arising from changes in benchmark interest rates. We may also enter into interest rate basis swap agreements that do not qualify as hedges for accounting purposes. The impact of changes in fair value of interest rate swap agreements is primarily presented in Interest expense.

Commodity Derivatives—We primarily use derivative instruments to manage our exposure to movements associated with agricultural commodity prices. We generally use exchange-traded futures and options contracts to minimize the effects of changes in the prices of agricultural commodities held as inventories or subject to forward purchase and sales contracts, but may also enter into OTC commodity transactions, including swaps, which are settled in cash at maturity or termination based on exchange-quoted futures prices. Changes in fair values of exchange-traded futures contracts, representing the unrealized gains and/or losses on these instruments, are settled daily, generally through our 100% owned futures clearing subsidiary. Forward purchase and sales contracts are primarily settled through delivery of agricultural commodities. While we consider these exchange-traded futures and forward purchase and sales contracts to be effective economic hedges, we do not designate or account for the majority of our commodity contracts as hedges. Changes in fair values of these contracts and related RMI are included in Cost of goods sold in the condensed consolidated statements of income. The forward contracts require performance of both us and the contract counterparty in future periods. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle.

Table of Contents

Ocean Freight Derivatives—We use derivative instruments referred to as freight forward agreements, or FFAs, and FFA options to hedge portions of our current and anticipated ocean freight costs. Changes in the fair values of ocean freight derivatives are recorded in Cost of goods sold.

Energy Derivatives—We use derivative instruments for various purposes, including to manage our exposure to volatility in energy costs and our exposure to market prices related to the sale of biofuels. Our operations use substantial amounts of energy, including natural gas, coal, and fuel oil, including bunker fuel. Changes in the fair values of energy derivatives are recorded in Cost of goods sold.

Other Derivatives—We may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives, to manage our exposure to credit risk and broader macroeconomic risks. The impact of changes in fair value of these instruments is presented in Cost of goods sold.

For more information, see Note 12 - Derivative Instruments And Hedging Activities to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures - Disclosure controls and procedures are the controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the principal executive and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

As of September 30, 2023, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as that term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.

Internal Control Over Financial Reporting - There have been no changes in the Company’s internal control over financial reporting during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. However, we continue to migrate certain processes from across our operations to shared business service models in order to consolidate back-office functions while standardizing our processes and financial systems globally. These initiatives are not in response to any identified deficiency or weakness in our internal controls over financial reporting. We plan to continue these initiatives in phases over the next several years and, accordingly, we have and will continue to align and streamline the design and operation of our internal controls over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. Specifically, we have continued migrating certain of our financial reporting systems in Argentina to our South American Enterprise Resource Planning (ERP) system, a process that is expected to carry on for several months, and which may result in changes to our internal controls over financial reporting relating to our Argentinian operations.

Additionally, management performed an evaluation of the impacts of the Ukraine-Russia War on our internal controls over financial reporting. In doing so management noted that, as a result of the war, we are currently unable to perform certain of our Ukrainian internal controls over financial reporting, primarily relating to on-site physical inspections of inventory, due to safety concerns, particularly in areas of active conflict. As of September 30, 2023, the carrying value associated with Company inventories in areas of active conflict has been substantially reserved. In response, management has implemented compensating controls, including using third party contractors to carry out visual inspections of the physical condition of our assets held at Ukrainian facilities in non-active conflict areas.

Table of Contents

PART II.

INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are involved in litigation and other claims, investigations and proceedings incidental to our business. While the outcome of these matters cannot be predicted with certainty, we believe the outcome of these proceedings, net of established reserves, will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

For a discussion of certain legal and tax matters see Note 15 - Commitments and Contingencies to our condensed consolidated financial statements included as part of this Quarterly Report on Form 10-Q. Additionally, we are a party to a large number of labor, civil and other claims, primarily relating to our Brazilian operations. We have reserved an aggregate of $69 million and $109 million, for labor and civil claims, respectively, as of September 30, 2023. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits. The civil claims relate to various legal proceedings and disputes, including disputes with suppliers and customers.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2022 Annual Report on Form 10-K and incorporated by reference in the “Risks Related to the Acquisition” and “Risks Related to the Redomestication” sections of the Company's definitive proxy statement filed with the SEC on August 7, 2023, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and the definitive proxy statement are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. Following are material updates to the risk factors previously disclosed in our 2022 Annual Report on Form 10-K:

We are subject to global and regional economic downturns and related risks.

The level of demand for our products is affected by global and regional demographic and macroeconomic conditions, including population growth rates and changes in standards of living. A significant downturn in global economic growth, or recessionary conditions in major geographic regions, may lead to reduced demand for agricultural commodities and food products, which could adversely affect our business and results of operations. Further, deteriorating economic and political conditions in our major markets, such as inflation, increased unemployment, decreases in disposable income, declines in consumer confidence, uncertainty about economic stability, or economic slowdowns or recessions, could cause a decrease in demand for our products.

Additionally, weak global economic conditions and adverse conditions in global financial and capital markets, including rising interest rates and constraints on the availability of credit, have in the past adversely affected, and may in the future adversely affect, the financial condition and creditworthiness of the financial institutions that serve as our lenders and as counterparties to the over-the-counter derivative instruments we use to manage risks and some of our customers, suppliers, and other counterparties, which in turn may negatively impact our financial condition and results of operations. Recently, concerns have arisen with respect to the financial condition of a number of banking organizations in the United States and globally. Although our exposure has been de minimis to these financial institutions, we continue to monitor our counterparty exposure. See "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Item 3. Quantitative and Qualitative Disclosures About Market Risk" for more information.

In 2022 and continuing into 2023, the United States has reported and is continuing to report high inflation rates and weaker GDP growth, with some economists forecasting a continuation of these conditions for the remainder of 2023. Brazil is experiencing a slowing GDP growth rate coupled with relatively high interest rates as it emerges from the COVID-19 pandemic, which may result in an uncertain economic and political environment that could in turn lead to reduced demand for our refined and specialty oils and milling products in the country. Additionally, a slowdown in China's economy over a prolonged period, including as a result of continuing impacts of COVID-19, population decline and other factors, could lead to reduced global demand for agricultural commodities. To the extent that such economic and political conditions negatively impact consumer and business confidence and consumption patterns or volumes, our business and results of operations could be significantly and adversely affected.

Table of Contents

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The following table is a summary of purchases of equity securities during the third quarter of 2023 by Bunge and any of its affiliated purchasers, pursuant to SEC rules.


Period	Total Number of Shares (or Units) Purchased	Average Price Paid per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs(1)	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs(1)
July 1, 2023 - July 31, 2023	—	$	—	—	$	2,000,000,000
August 1, 2023 - August 31, 2023	2,490,354	$	113.02	2,490,354	$	1,718,528,122
September 1, 2023 - September 30, 2023	1,837,182	$	112.32	1,837,182	$	1,512,169,533
Total	4,327,536	$	112.73	4,327,536

(1) Program was originally established in October 2021 for the repurchase of up to $500 million issued and outstanding common shares. On June 12, 2023, Bunge's Board of Directors approved the expansion of the existing program for the repurchase of Bunge’s issued and outstanding common shares. At the time, approximately $300 million of capacity for the repurchase of Bunge common shares remained available under the existing program and Bunge's Board of Directors approved the expansion of the program by an additional $1.7 billion, for an aggregate purchase price of $2.0 billion. The program continues to have an indefinite term. To date under the program, 6,436,651 common shares were repurchased for $688 million.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

(a) The exhibits in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.

Table of Contents

EXHIBIT INDEX


10.1		$1.665 billion Credit Agreement, dated as of July 7, 2023, by and among Bunge Limited Finance Corp., as Borrower, CoBank, ACB, as Administrative Agent and Lead Arranger, and the several lenders from time to time parties thereto (incorporated by reference from the Registrant’s Form 8-K filed on July 11, 2023)
10.2		Guaranty, dated as of July 7, 2023, by Bunge Limited and Bunge Global SA, as Guarantor, to CoBank, ACB, as Administrative Agent under the $1.665 billion Credit Agreement incorporated as Exhibit 10.1 into this Quarterly Report on Form 10-Q (incorporated by reference from the Registrant’s Form 8-K filed July 11, 2023)
22.1	*	Subsidiary Issuers of Guaranteed Securities
31.1	*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
31.2	*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
32.1	**	Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
32.2	**	Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101 SCH		XBRL Taxonomy Extension Schema Document
101 CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101 LAB		XBRL Taxonomy Extension Labels Linkbase Document
101 PRE		XBRL Taxonomy Extension Presentation Linkbase Document
101 DEF		XBRL Taxonomy Extension Definition Linkbase Document
101 INS		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith.

** Furnished herewith.

E-1

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	BUNGE LIMITED


Date: October 26, 2023	By:	/s/ John W. Neppl
		John W. Neppl
		Executive Vice President, Chief Financial Officer


		/s/ J. Matt Simmons, Jr.
		J. Matt Simmons, Jr.
		Controller and Principal Accounting Officer